carbapenems has been researched along with Bacteremia in 422 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (0.95) | 18.2507 |
| 2000's | 45 (10.66) | 29.6817 |
| 2010's | 265 (62.80) | 24.3611 |
| 2020's | 108 (25.59) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Chen, Y; Fang, X; Hang, Y; Hu, L; Hu, X; Luo, H; Xiao, Y; Xiong, J; Zhong, Q; Zhu, H; Zou, S | 1 |
| Alp, E; Dinç, G; Doğanay, M; Eryılmaz-Eren, E; Kontaş, O | 1 |
| Ko, WC; Lee, NY; Lo, CL; Syue, LS; Tsai, WC | 1 |
| Costa, SF; Deo, B; Farrel Côrtes, M; Perdigão, L; Rizek, C; Rodrigues Pires de Campos, L; Santos, S | 1 |
| Arias, CA; Arias, R; Baum, K; Bonomo, RA; Chambers, HF; Chen, L; Cober, E; Doi, Y; Earley, M; Evans, S; Fowler, VG; Fries, BC; Gao, H; Hanson, BM; Hill, C; Kanj, SS; Komarow, L; Kreiswirth, BN; Li, L; Liu, Z; Luterbach, C; Manca, C; Marimuthu, K; Marshall, SH; Munita, JM; Ordoñez, K; Patel, R; Paterson, DL; Reyes, J; Rudin, SD; Salcedo, S; Satlin, MJ; Stryjewski, ME; Valderrama-Beltrán, SL; van Duin, D; Villegas, MV; Wang, M; Weston, G; Yu, Y | 1 |
| Dong, H; Li, X; Liu, C; Ming, L; Xu, M | 1 |
| Chang, H; Liu, CP; Sun, FJ; Wang, NY; Wu, AY | 1 |
| Barros, A; Beck, E; Bergo, P; David, L; Monroy, H; Rigatto, MH | 1 |
| Gargalianos-Kakolyris, P; Kalofissoudis, Y; Kantzanou, M; Kotteas, E; Maltezou, HC; Michou, I; Moussas, N; Pantazis, N; Pantos, C; Papanikolopoulou, A; Syrigos, KN; Tountas, Y; Tsakris, A | 1 |
| Cai, W; Chen, J; Ye, J; Ye, Y; Ying, P | 1 |
| Ai, W; Chen, L; Cienfuegos-Gallet, AV; Kreiswirth, BN; Yu, F; Zhou, Y | 1 |
| Akhmedov, M; Drokov, M; Fedorova, A; Klyasova, G; Kuzmina, L; Parovichnikova, E; Vasilyeva, V | 1 |
| Mo, Y | 1 |
| Bhowmick, T; Chen, L; Derti, S; Eilertson, B; Gomez-Simmonds, A; Hoffman, KL; Hong, T; Jenkins, SG; Juretschko, S; Kim, AC; Kreiswirth, BN; Levi, MH; Marino, J; Satlin, MJ; Seo, SK; Sperber, SJ; Tang, YW; Uhlemann, AC; Walsh, TJ; Weinstein, MP; Westblade, LF; Weston, G | 1 |
| Du, FL; Huang, QS; Liao, W; Liu, Y; Wan, LG; Wei, D; Xiang, TX; Xiong, Z; Zhang, S; Zhang, W | 1 |
| Bang, JH; Cheon, S; Choe, PG; Choi, HJ; Jung, SI; Jung, Y; Kang, YM; Kim, CJ; Kim, ES; Kim, HB; Kim, SE; Kim, YJ; Kwak, YG; Lee, CM; Lee, S; Lee, SH; Park, KH; Park, WB; Song, KH | 1 |
| Beeker, A; Coenen, JLLM; de Jonge, NA; de Kreuk, A; Herbers, AH; Janssen, JJWM; Kramer, MHH; Lissenberg-Witte, B; Sikkens, JJ; van Agtmael, MA; Vasmel, W; Ypma, P; Zweegman, S | 1 |
| Ahmed, W; Al-Hamzi, MA; Al-Turkistani, HH; Aljishi, Y; Almaghrabi, RS; Alodini, K; Alosaimi, R; Alraddadi, BM; Alshukairi, AN; Alswaiel, R; Althaqafi, A; Anani, M; Attalah, D; Eljaaly, K; Hassan, W; Heaphy, ELG; Hefni, LK; Qutub, MO; Saeedi, MF | 1 |
| Jung, EJ; Jung, Y; Kim, JY; Lee, J; Park, JJ; Seo, YB | 1 |
| Armiñanzas-Castillo, C; Bahamonde-Carrasco, A; Boix-Palop, L; Cuquet-Pedragosa, J; Del Arco-Jiménez, A; Fernández-Natal, I; Fernandez-Suarez, J; Galan-Sanchez, F; Goikoetxea-Aguirre, AJ; Jóver-Saenz, A; León Jiménez, E; Lopez-Cortes, LE; López-Hernández, I; Martínez Pérez-Crespo, PM; Morán Rodríguez, MÁ; Mussa, M; Reguera-Iglesias, JM; Retamar-Gentil, P; Rodríguez-Baño, J; Sánchez-Calvo, JM; Sánchez-Porto, A; Smithson-Amat, A; Sousa-Dominguez, A; Vinuesa-García, D | 1 |
| Chen, Y; Cui, Y; Deng, J; Guo, P; Huang, B; Kong, Y; Liao, K; Liu, P; Peng, Y; Wu, Z | 1 |
| Chronopoulou, G; Gargalianos-Kakolyris, P; Kandalepas, G; Kantzanou, M; Kartsonakis, I; Kritikou, H; Maltezou, HC; Pantazis, N; Papadopoulos, T; Papanikolopoulou, A; Pentzouris, A; Tsakris, A | 1 |
| Alby, K; Ammazzalorso, A; Anesi, JA; Bilker, WB; Blumberg, EA; Han, JH; Lautenbach, E; Omorogbe, J; Pineles, L; Tamma, PD; Thom, KA; Tolomeo, P; Werzen, A | 1 |
| Abe, S; Amarasiri, M; Aryukarn, A; Badavath, VN; Chantaravisoot, N; Chatsuwan, T; Hao, LY; Higgins, PG; Hongsing, P; Hurst, C; Kicic, A; Kueakulpattana, N; Kupwiwat, R; Laowansiri, M; Leelahavanichkul, A; Liao, T; Luk-In, S; Ngamwongsatit, N; Nilgate, S; Ounjai, P; Phattharapornjaroen, P; Ragupathi, NKD; Rirerm, U; Saethang, T; Shein, AMS; Srisakul, S; Techawiwattanaboon, T; Wannigama, DL; Yonpiam, M | 1 |
| Ferraro, DK; Garcia, ME; Gomez, S; Mastroianni, A; Pérez, G; Picollo, M; Reijtman, V; Rosanova, MT | 1 |
| Doi, Y; Enokida, T; Harada, S; Hayama, B; Hoashi, K; Ohkushi, D; Sakurai, A; Suzuki, M; Takeda, K; Takehana, K | 1 |
| Bae, JY; Bang, JH; Cheon, S; Choe, PG; Choi, HJ; Jung, SI; Jung, Y; Kang, YM; Kim, CJ; Kim, ES; Kim, HB; Kim, SE; Kim, YS; Kwak, YG; Lee, CM; Lee, S; Lee, SH; Lee, SS; Park, KH; Park, WB; Song, JE; Song, KH | 1 |
| Barros, A; Bergo, P; Gonçalves, L; Guasso, I; Pedroso, S; Ramos, F; Rigatto, MH; Zavascki, AP | 1 |
| Himmel, LE; Kunkle, DE; Maloney, KN; Monteith, AJ; Sheldon, JR; Skaar, EP | 1 |
| Guzmán-Cedillo, AE; Jang, BH; Kang, JH; Kwon, S; Lee, MS; Park, SJ | 1 |
| Holm, K; Lindberg, Å; Nilson, B; Sarasoja, M; Torisson, G; Wide, D | 1 |
| Chen, TL; Cheng, A; Chiang, TT; Huang, TW; Kuo, SC; Lee, YT; Liu, CP; Liu, YM; Sun, JR; Wang, YC; Yang, YS | 1 |
| De Filippis, A; Della Rocca, MT; Finamore, E; Foglia, F; Galdiero, M; Manfredini, M; Melardo, C; Montella, F; Nastri, BM | 1 |
| Lowe, M; Perovic, O; Shuping, L | 1 |
| Cameron, A; Debnath, A; Dobrzynski, D; Martin, AJ; Pillinger, KE; Shulder, S | 1 |
| Chang, LY; Chen, JM; Huang, LM; Lee, PI; Liu, YC; Lu, CY; Yen, TY | 1 |
| Kim, MN; Lee, J; Park, S; So, H | 1 |
| Aysert-Yildiz, P; Dizbay, M; Habibi, H; Özgen-Top, Ö | 1 |
| Bomers, MK; de Jonge, NA; de la Court, JR; Heijmans, J; Lambregts, MMC; Schade, RP; Schoffelen, AF; Sigaloff, KCE; van der Bruggen, T; Woudt, SHS | 1 |
| Chen, L; Cheng, S; Chu, TY; Clancy, CJ; Driscoll, E; Fleres, G; Hao, B; Kreiswirth, BN; Liu, G; Newbrough, A; Nguyen, MH; Shields, RK; Squires, KM | 1 |
| de Jonge, NA; de la Court, JR; Heijmans, J; Huynh, J; Schade, RP; Sieswerda, E; Sigaloff, KCE; van Dijk, K | 1 |
| Chen, J; Cui, Y; Huang, X; Ma, H; Ma, S; Niu, R; Pan, P; Peng, W; Rao, M; Su, L; Yang, H; Zhang, P; Zhu, F | 1 |
| Cai, Y; Wang, J; Wang, Y; Xiao, Q; Xu, J; Zhang, H; Zhu, M | 1 |
| Abidi, K; Akova, M; Alsisi, A; Arvaniti, K; Aslan, AT; Barbier, F; Bassetti, M; Bracht, H; Buetti, N; Conway Morris, A; De Bus, L; De Waele, J; Elhadi, M; Ferrer, R; Gurjar, M; Hayashi, Y; Jeon, K; Leone, M; Lipman, J; Paiva, JA; Povoa, P; Qiu, H; Ruckly, S; Staiquly, Q; Tabah, A; Timsit, JF; Zand, F | 1 |
| Abraham, A; Balaji, V; Bhanuprasad, K; Chacko, B; George, B; George, MM; John, GM; Korula, A; Kulkarni, UP; Mathews, V; Premkumar, PS; Sathya Kumar, AM; Shankar, C; Subramani, K; Varghese, GM | 1 |
| Bilen, NM; Cilli, F; Güner Özenen, G; Kurugöl, Z; Ozdemir Karadas, N; Ozek, G; Sahbudak Bal, Z; Yazici, P; Yildirim Arslan, S | 1 |
| Atsuta, Y; Doki, N; Fukushima, K; Kobayashi, T; Najima, Y; Ohashi, K; Sakaguchi, M; Sekiya, N; Shingai, N; Toya, T | 1 |
| Chu, W; Huang, L; Jia, J; Sheng, Y; Xu, A; Xu, H; Zhang, L | 1 |
| Choi, MC; Joo, DJ; Kim, DG; Kim, MS; Lee, JG; Min, EK; Yim, SH | 1 |
| Banaei, N; Bounthavong, M; Deresinski, S; Diep, C; Ha, D; Lu, B; Wong, M | 1 |
| Borrazzo, C; Bruni, A; Garofalo, E; Gullì, S; Lionello, R; Longhini, F; Marascio, N; Matera, G; Quirino, A; Romeo, F; Russo, A; Serapide, F; Serraino, R; Torti, C; Trecarichi, EM | 1 |
| Gopakumar, KG; Jithin, TK; Nair, C; Nirmal, G; Parthiban, R | 1 |
| Holmes, AH; Nasomsong, W; Panuvatvanich, B; Rawson, TM; Vasikasin, V | 1 |
| Akbaş, T; Akdoğan, Ö; Akova, M; Aksoy, F; Akyol, A; Aslan, AT; Barbier, F; Batirel, A; Bayindir, Y; Bilir, Y; Buetti, N; Çeşme, U; Çolak, O; Dağ, O; Dindar, EK; Eroğlu, A; Erol, Ç; Ersöz, G; Ferlicolak, L; Gürbüz, Y; Guzeldağ, S; Kalem, AK; Karaali, R; Köylü, B; Öztürk, B; Ruckly, S; Selçuk, M; Staiquly, Q; Sungurtekin, H; Tabah, A; Timsit, JF; Timuroğlu, A; Tunay, B; Yilmaz, M | 1 |
| Bhattacharya, S; Chakrabarti, A; Dutta, RP; Majumdar, T | 1 |
| Chen, Z; Feng, S; Han, M; Jiang, E; Mi, Y; Wang, J; Xiao, Z; Zhang, F; Zhang, T; Zhao, Y; Zhen, S; Zhu, X | 1 |
| Lu, J; Meng, H; Niu, M; Yang, J; Zhou, Y; Zhu, H | 1 |
| Breda, GL; Funke, VAM; Lima, ACM; Loth, G; Nabhan, SK; Nogueira, KDS; Santos, ES; Tomaz, APO | 1 |
| Ávila-Núñez, M; Celestino, P; García-Formoso, L; Garrido-Ventín, M; Lima, O; Martinez-Lamas, L; Pérez-Landeiro, A; Pérez-Rodríguez, MT; Represa, M; Rubianes, M; Rubiñán, P; Sousa, A; Vasallo-Vidal, F | 1 |
| Aldieri, C; Badalucco Ciotta, F; Bassetti, M; Calabresi, A; Cattardico, G; Cattelan, AM; Corcione, S; Cortegiani, A; D'Amico, F; De Rosa, FG; Del Bono, V; Del Puente, F; Di Meco, G; Di Pilato, V; Fanelli, C; Francisci, D; Giacobbe, DR; Giacomini, M; Gori, A; Graziani, L; Lombardi, A; Losito, AR; Marchese, A; Marelli, C; Mazzitelli, M; Merli, M; Mikulska, M; Milazzo, M; Momesso, E; Mularoni, A; Oltolini, C; Pallotto, C; Pontali, E; Raffaelli, F; Russelli, G; Serino, FS; Signori, A; Spinicci, M; Torti, C; Trecarichi, EM; Vena, A | 1 |
| DeRisi, JL; Detweiler, AM; Engel, J; Hao, S; Langelier, CR; Macmillan, H; Mekonen, H; Miller, SA; Neff, N; Sanchez-Guerrero, E; Schwartz, BS; Spottiswoode, N | 1 |
| Kim, JY; Kim, SB; Lee, WJ; Sohn, JW; Suh, JW; Yoon, YK | 1 |
| Bastian, S; Breurec, S; Camous, L; Carles, M; Dequidt, T; Nacher, M; Pommier, JD; Thiery, G; Tressieres, B; Valette, M | 1 |
| Astocondor, L; Garcia, C; Hinostroza, N; Jacobs, J; Ochoa, T | 1 |
| Çağ, Y; Can, F; Ergonul, O; Hacıseyitoğlu, D; Işık, ME; Menekşe, Ş; Şahin, S | 1 |
| Campos, J; Diaz Högberg, L; Eckmanns, T; Giske, CG; Grundmann, H; Heuer, OE; Jarlier, V; Johnson, AP; Kahlmeter, G; Monen, J; Monnet, DL; Pantosti, A; Rossolini, GM; Simonsen, GS; van de Sande-Bruinsma, N; Vatopoulos, A; Żabicka, D; Žemličková, H | 1 |
| Leung, CH; Liu, CP | 1 |
| Jeong, SH; Kim, D; Yoon, EJ | 1 |
| Park, SW | 1 |
| Bielecki, JM; Budhram, DR; Mac, S; Patel, SN; Sander, B | 1 |
| Alonso Acero, L; Gutiérrez Arroyo, A; Ramos Ramos, JC; Romero Gómez, MP | 1 |
| Asmara, W; Dwiprahasto, I; Mulyono, B; Sianipar, O | 1 |
| David, SSB; Maor, Y; Schwartz, O; Yossepowitch, O; Zohar, I | 1 |
| Harris, PNA; Henderson, A; Paterson, DL | 1 |
| Cheok, SJH; Chew, KL; Heng, ST; Lye, DC; Ng, TM; Ng, WHW; Tambyah, PA; Tan, SH; Wan, S; Wu, JE; Yap, MY; Yong, J | 1 |
| Cao, X; Chang, H; Chen, S; Chen, Y; Huang, R; Wei, J; Wu, C; Yan, X; Yao, K; Zhou, W; Zuo, L | 1 |
| Anastassiou, ED; Assimakopoulos, SF; Christofidou, M; Fligou, F; Karamouzos, V; Kolonitsiou, F; Marangos, M; Papachristou, E; Papadimitriou-Olivgeris, M; Solomou, A; Spiliopoulou, I; Spyropoulou, A; Vamvakopoulou, S | 1 |
| Goel, N; Wattal, C | 1 |
| Busch, DH; Katchanov, J; Lahmer, T; Rothe, K; Schmid, RM; Schneider, J; Spinner, CD; Wantia, N; Waschulzik, B | 1 |
| Cui, K; Dong, H; Dong, Y; Feng, W; Ma, C; Shan, Y; Wang, T; Zhang, D | 1 |
| Cho, SY; Chung, DR; Ha, YE; Huh, HJ; Huh, K; Kang, CI; Kim, MJ; Kim, SH; Ko, JH; Lee, NY; Peck, KR; Song, JH | 1 |
| Gommers, D; Persoon, MC; Severin, JA; Voor In't Holt, AF; Vos, MC; Wielders, CCH | 1 |
| Dou, Q; Hu, Y; Huang, Z; Li, J; Liu, J; Tao, X; Wang, H; Zou, M | 1 |
| Alessia, L; Andreoni, M; Angeletti, S; Cella, E; Ciccozzi, M; Favaro, M; Florio, L; Fontana, C; Gherardi, G; Leoni, D; Mirandola, W; Rose, DD; Salemi, M; Sarmati, L; Zehender, G | 1 |
| Chen, PL; Ko, WC; Lee, NY; Li, CW; Li, MC; Syue, LS; Tsai, CS | 1 |
| Ito, A; Kobayashi, K; Mitsuboshi, S; Nakashita, M; Suzuki, M; Takahashi, S; Tsugita, M; Tsuruma, N; Watanabe, K | 1 |
| Bamford, C; Bhola, P; Chibabhai, V; Ismail, H; Mbelle, N; Nana, T; Perovic, O; Quan, V; Ramjathan, P; Singh-Moodley, A; Smith, M; Swe Swe-Han, K; Wadula, J; Whitelaw, A | 1 |
| Shen, P; Wang, Y; Xiao, T; Xiao, Y; Yu, X; Zhang, S; Zhou, Y; Zhu, Y | 1 |
| Chang, YJ; Chen, CL; Chen, MC; Chiu, CH; Feng, Y; Li, HC; Su, LH; Yang, HP; Yu, MJ | 1 |
| Asai, K; Fujita, A; Imoto, W; Kakeya, H; Kaneko, Y; Kawaguchi, T; Kuwabara, G; Nakaie, K; Niki, M; Okada, Y; Shibata, W; Watanabe, T; Yamada, K; Yamairi, K; Yoshii, N; Yukawa, S | 1 |
| Bruns, AHW; de Groot, MCH; Niessen, FA; Raijmakers, RAP; van der Bruggen, T; van Mourik, MSM | 1 |
| Almaeen, AH; Bandy, A | 1 |
| Cen, H; Zhang, L | 1 |
| Cares Network, OBOT; Chen, H; Li, H; Liu, Y; Wang, H; Wang, Q; Zhao, C | 1 |
| Choi, YK; Jeon, J; Lee, J; Park, JJ; Seo, YB | 1 |
| Dai, Y; Jiao, Z; Lin, G; Pan, J; Wen, X; Yu, X; Zhang, C; Zhou, Z | 1 |
| Ariyasu, M; Bassetti, M; Doi, Y; Echols, R; Ferrer, R; Lodise, TP; Matsunaga, Y; Naas, T; Nagata, TD; Niki, Y; Paterson, DL; Portsmouth, S; Torre-Cisneros, J; Toyoizumi, K; Wunderink, RG | 1 |
| Chai, W; Chang, Q; Chen, Q; Chen, Z; Liu, H; Pan, H; Sun, F; Wang, Y; Zhang, G; Zhang, M; Zhou, J; Zhu, D | 1 |
| Cai, B; Hsu, WC; Kanakamedala, H; Lodise, TP | 1 |
| Aitken, SL; Arias, CA; Bhatti, MM; Galloway-Peña, J; Greenberg, DE; Hanson, BM; Kalia, A; Kim, J; Li, X; Pifer, R; Sahasrabhojane, P; Shelburne, SA; Shropshire, WC | 1 |
| Aguado, JM; Cano, Á; Carratalà, J; Clemente, WT; Cohen-Sinai, N; Cordero, E; Coussement, J; David, MD; Eriksson, BM; Fernández-Ruiz, M; Freire, MP; Grossi, PA; Gunseren, F; Gutiérrez-Gutiérrez, B; Hamiyet Demirkaya, M; Iyer, RN; Koçak Tufan, Z; Loeches, B; López-Medrano, F; Martín-Dávila, P; Martínez-Martínez, L; Mehta Steinke, S; Merino, E; Montejo, M; Mularoni, A; Oriol, I; Pascual, Á; Paul, M; Pérez-Nadales, E; Pierrotti, LC; Pilmis, B; Rana, M; Rizzi, M; Rodríguez-Baño, J; Roilides, E; San-Juan, R; Seminari, EM; Soldani, F; Tan, BH; Torre-Cisneros, J; Valerio, M; van Delden, C | 1 |
| Cisera, K; Hughes, C; Rogers, B; Taylor, L; Xie, O | 1 |
| Chen, PL; Ko, WC; Lee, NY; Li, CW; Li, MC; Lo, CL; Syue, LS | 1 |
| Bower, CW; Farley, MM; Howard-Anderson, JR; Jacob, JT; Satola, SW; Sexton, ME; Smith, G | 1 |
| Caeiro, JP; Hernández, D; Lipari, FG; Saka, HA; Vilaró, M | 1 |
| Bartzavali, C; Christofidou, M; Fligou, F; Georgakopoulou, A; Kolonitsiou, F; Marangos, M; Mplani, V; Papadimitriou-Olivgeris, M; Spiliopoulou, I | 1 |
| Feng, C; Li, H; Lv, X; Qu, J | 1 |
| Babar, ZU; Dodani, SK; Nasim, A | 1 |
| Bernardi, M; Castagna, A; Castiglion, B; Ciceri, F; Clerici, D; Corti, C; Farina, F; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Mastaglio, S; Oltolini, C; Pavesi, F; Peccatori, J; Ripa, M; Scarpellini, P; Tassan Din, C | 1 |
| Chen, TL; Huang, TW; Kuo, SC; Lee, YT; Lin, PY; Liu, CP; Liu, IF; Liu, YM; Wang, FD; Wang, YC; Yang, YS | 1 |
| Costa, SF; de Castro Lima, VAC; do Prado, GVB; Freire, MP; Guimarães, T; Levin, AS; Martins, RCR; Mendes, ET; Perdigão-Neto, LV; Rocha, V; Rossi, F; Spadão, F | 1 |
| Shi, Q; Xiao, T; Xiao, Y; Yang, K; Ye, J; Zhou, Y; Zhu, Y | 1 |
| Glaser, A; Jahangir, A; Mobarakai, N; Sahra, S; Sharif, MA | 1 |
| Bai, L; Gao, X; Geng, Y; He, A; Lei, J; Lei, K; Liu, J; Liu, Z; Tang, YW; Tenover, FC | 1 |
| Cai, B; Kanakamedala, H; Shields, RK; Zhou, Y | 1 |
| Cai, J; Cui, W; Huang, J; Qian, Z; Song, F; Zhang, G; Zhang, K; Zheng, C; Zhou, F; Zhou, H | 1 |
| Dai, W; Huang, YL; Hung, YP; Ko, WC; Lin, TC; Lin, WT | 1 |
| Cai, Y; Liang, B; Wang, J; Zhang, H | 1 |
| Chen, C; Chen, YB; Wang, HB; Zhang, BL; Zhu, XY; Zhu, YH | 1 |
| Hong, MY; Hsieh, CC; Hung, YP; Ko, WC; Lee, CC; Lee, CH | 1 |
| Bonten, MJ; Bravo-Ferrer, J; Cuperus, N; Daikos, G; de Kraker, M; Feifel, J; Folgori, L; Goossens, H; Gutiérrez-Gutiérrez, B; Kostyanev, T; O'Brien, S; Pascual, A; Raka, L; Rodríguez-Baño, J; Sojo-Dorado, J | 1 |
| Daikos, GL; Kosmidis, C; Kotsopoulou, M; Pantazatou, A; Perlorentzou, S; Piperaki, ET; Poulli, A; Samarkos, M; Tofas, P; Triantafyllopoulou, ID; Vagia, M | 1 |
| Chen, L; Clancy, CJ; Doi, Y; Kreiswirth, BN; Marini, RV; Nguyen, MH; Potoski, BA; Press, EG; Shields, RK | 1 |
| Abdala, E; Akova, M; Álvarez, R; Cano, A; Carratalà, J; Cervera, C; Clemente, WT; Freifeld, A; Gómez, L; Gottlieb, T; Gudiol, C; Gurguí, M; Herrera, F; Maestro-de la Calle, G; Manzur, A; Martín-Dávila, P; Maschmeyer, G; Meije, Y; Montejo, M; Peghin, M; Rodríguez-Baño, J; Royo-Cebrecos, C; Ruiz-Camps, I; Sukiennik, TC; Tebe, C | 1 |
| Dong, F; Guo, L; Liu, G; Lu, J; Lyu, S; Song, W; Wang, Y; Yang, Y; Yao, K; Zhang, Y; Zheng, H | 1 |
| Al-Hasan, MN; Albrecht, HA; Bookstaver, PB; Hammer, KL; Justo, JA; Kohn, J; Nimmich, EB; Smith, TJ; Troficanto, C | 1 |
| Abbo, L; Gebrezgi, MT; Jimenez, A | 1 |
| Adamis, G; Christodoulou, S; Chrysanthakopoulou, M; Giamarellos-Bourboulis, EJ; Gkizeli, K; Karampela, I; Karlis, G; Kyriazopoulou, E; Safarika, A; Veliki, N | 1 |
| Choi, JK; Joo, EJ; Ko, JH; Lee, NR; Moon, SY; Park, DA; Peck, KR | 1 |
| Horvath, A; Ostorhazi, E; Otvos, L; Szabo, D | 1 |
| Chen, CT; Chen, TL; Kuo, SC; Lee, YT; Liu, CP; Liu, YM; Wang, YC; Yang, YS | 1 |
| Cha, MK; Cho, SY; Chung, DR; Ha, YE; Kang, CI; Kim, JY; Lee, JH; Lee, NY; Park, GE; Peck, KR; Seok, H; Song, JH | 1 |
| Chang, HT; Chang, SC; Chen, YC; Cheng, A; Chuang, YC; Sheng, WH; Sun, HY; Yang, CJ; Yang, JL | 1 |
| Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HS; Kim, SK; Lee, DG; Lee, JW; Park, BK | 1 |
| Fujimoto, H; Kakeya, H; Kaneko, Y; Namikawa, H; Oinuma, KI; Shuto, T; Takemoto, Y; Tochino, Y; Yamada, K | 1 |
| Lee, CH; Liu, JW; Ting, SW | 1 |
| Gandra, S; Gupta, P; Kaur, A; Laxminarayan, R; Mehta, Y; Sengupta, S | 1 |
| Ambretti, S; Bartoletti, M; Bartoloni, A; Bassetti, M; Cauda, R; Corcione, S; De Rosa, FG; Del Bono, V; Giacobbe, DR; Giannella, M; Lewis, RE; Losito, AR; Marchese, A; Raffaelli, F; Rossolini, GM; Saffioti, C; Spanu, T; Tedeschi, S; Trecarichi, EM; Tumbarello, M; Viale, P; Viscoli, C | 1 |
| Kousouli, E; Polimeri, K; Politi, L; Pournaras, S; Themeli-Digalaki, K; Tsakris, A; Vrioni, G; Zarkotou, O | 1 |
| Amat, T; Cisneros, JM; Garnacho-Montero, J; Gracia-Ahufinger, I; Gutiérrez-Pizarraya, A; Machuca, I; Pérez-Nadales, E; Torre-Cisneros, J; Torre-Giménez, Á | 1 |
| Castanheira, M; Davis, AP; Deshpande, LM; Le, J; Turner, N | 1 |
| Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; Gasch, O; Giamarellou, H; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hernández, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Molina Gil-Bermejo, J; Oliver, A; Palacios-Baena, ZR; Paño-Pardo, JR; Pascual, Á; Paterson, DL; Peña, C; Pérez, F; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Schwaber, MJ; Souli, M; Tacconelli, E; Torre-Cisneros, J; Tumbarello, M; Venditti, M; Viale, P | 1 |
| Carbo, J; Conway, EL; Kurtzhalts, K; Lin, K; Mergenhagen, KA; Ott, MC; Sellick, JA | 1 |
| Arena, F; Fani, L; Frullini, A; Laureano, R; Mannini, D; Meini, S; Passaleva, MT; Ripoli, A; Roberts, AT; Rossolini, GM; Sbrana, F; Tascini, C | 1 |
| Amigo, U; Batista, MV; Chaves, L; Costa, SF; Guimaraes, T; Leite, GC; Levin, AS; Martins, RR; Neves, P; Ramos, J; Rizek, C; Salomão, M; Tomich, LM | 1 |
| Acker, EC; Al-Hasan, MN; Bookstaver, PB; Justo, JA; Kohn, JE | 1 |
| Abdala, E; Cury, AP; da Silva Duarte, AJ; da Silva, AM; Girardello, R; Martins, LF; Morais, C; Rossi, F; Setubal, JC | 1 |
| Huang, D; Jacobs, DM; Minhaj, F; Parker, A; Rao, GG; Safir, MC | 1 |
| Cai, J; Cao, B; Chen, H; Gu, B; Guo, Z; Hu, T; Huang, J; Huang, W; Jia, X; Jin, L; Li, B; Li, H; Li, W; Liao, K; Liu, L; Ma, X; Man, S; Pei, F; Tian, J; Wang, H; Wang, Q; Wang, S; Wen, H; Xie, L; Yang, C; Yang, H; Yin, Y; Zhang, L; Zhang, X; Zhang, Y; Zou, C | 1 |
| Cha, CJ; Jeon, JH; Jeong, BC; Kim, YB; Lee, CR; Lee, JH; Lee, SH; Park, KS | 1 |
| Bland, CM; Chastain, DB; Cretella, DA; White, BP | 1 |
| Akalın, H; Alışkan, HE; Aydın, G; Aydın, M; Azap, A; Azap, Ö; Başaran, S; Bilgin, H; Çakar, ŞE; Can, F; Çavuş, SA; Demir, NA; Demirkaya, H; Demiroğlu, YZ; Erdinç, Ş; Ergen, P; Ergönül, Ö; Hatipoğlu, Ç; Karakoç, Ç; Karaoğlan, I; Kaya, Ş; Keske, Ş; Memikoğlu, O; Menekşe, Ş; Mülazımoğlu, L; Tekin, S; Tezer, Y; Tümtürk, A; Ural, O; Yardımcı, C; Yılmaz, E | 1 |
| Aubry, A; Charles-Nelson, A; Compain, F; Dépret, F; Fernandez-Gerlinger, MP; Fournier, A; Katsahian, S; Mainardi, JL | 1 |
| Cienfuegos-Gallet, AV; Higuita-Gutiérrez, LF; Jiménez Quiceno, JN; López-López, L; Vargas-Alzate, CA | 1 |
| Cao, SJ; Feng, D; Wan, LP; Wang, GJ; Xiao, XG; Xu, H; Zheng, SH | 1 |
| Katsiari, M; Mavroidi, A; Nikolaou, C; Platsouka, ED | 1 |
| Akeda, Y; Hagiya, H; Kimura, K; Nishi, I; Tomono, K; Yamamoto, N; Yoshida, H | 1 |
| Li, XX; Liu, WS; Wu, HG; Zhu, M | 1 |
| Chen, HY; Chiueh, TS; Chou, YC; Hsu, WJ; Huang, LS; Sun, JR; Wang, YC; Yang, YS | 1 |
| Choi, HJ; Choi, JY; Kim, DG; Kim, SI; Kim, YJ; Lee, YD; Yoon, SK; You, YK | 1 |
| Chai, LYA; Chee, YL; Chng, WJ; Hsu, LY; Jin, J; Khoo, AL; Koh, LP; Lim, BP; Lim, SE; Poon, LM; Teng, M; Ying, D; Zhao, YJ | 1 |
| Li, Y; Liu, J; Liu, Y; Shen, L; Yu, J; Zhu, W | 1 |
| Choi, JK; Joo, EJ; Ko, JH; Lee, NR; Moon, SY; Park, DA; Peck, KR; Son, SK | 1 |
| Dong, F; Guo, LY; Liu, G; Song, WQ; Wang, Y; Zhang, Y | 1 |
| Adjemian, J; Danner, RL; Dekker, JP; Fridkin, S; Hooper, DC; Kadri, SS; Klompas, M; Lai, YL; Palmore, TN; Powers, JH; Prevots, DR; Rhee, C; Ricotta, E; Spaulding, AB; Suffredini, AF | 1 |
| Bassetti, M; Giamarellos-Bourboulis, EJ; Graziano, E; Kotsaki, A; Righi, E; Routsi, C | 1 |
| Huang, YC; Lin, YT; Wang, FD; Wu, PF | 1 |
| Guo, Q; Hu, F; Li, Y; Su, J; Wang, M; Wu, S; Xu, S | 1 |
| Aviv, T; Dadon, M; Daniel, C; Katz, D; Kaye, KS; Lazarovitch, T; Marchaim, D; Tal-Jasper, R; Zaidenstein, R | 1 |
| Chen, SL; Heng, ST; Lye, DC; Ng, TM; Wong, JGX | 1 |
| Hayden, MK; Won, SY | 1 |
| Chen, Z; Kang, M; Li, M; Liu, M; Song, Q; Wu, L; Xie, Y; Zhao, D | 1 |
| Bassis, C; Cisneros, EC; Dangana, T; Fogg, L; Hayden, MK; Lin, MY; Lolans, K; Moore, NM; Okamoto, K; Rhee, Y; Schoeny, M; Seekatz, A; Shimasaki, T; Weinstein, RA; Yelin, RD; Young, VB | 1 |
| Kano, KI; Nishiyama, K; Shime, N | 1 |
| Godreuil, S; Hantova, S; Jean-Pierre, H; Jumas-Bilak, E; Laurens, C; Licznar-Fajardo, P; Martinez, O | 1 |
| Andrawus, ER; Bar-Yoseph, H; Cohen, N; Even Dar, R; Geffen, Y; Hussein, K; Korytny, A; Paul, M | 1 |
| Alvares, PA; Arnoni, MV; da Silva, CB; Mimica, MJ; Sáfadi, MAP | 1 |
| Cho, EB; Choi, SH; Chung, JW; Lee, MK | 1 |
| Ito, A; Kobayashi, K; Mitsuboshi, S; Nakashita, M; Takahashi, S; Tsugita, M; Tsuruma, N; Watanabe, K | 1 |
| Liu, CP; Lu, HP; Luor, T | 1 |
| Antoniadou, E; Iosifidis, E; Kontopoulou, K; Malisiovas, N; Malli, E; Metallidis, S; Petinaki, E; Tasioudis, P; Vatopoulos, A | 1 |
| Bernards, ST; de Boer, MGJ; Hendriks, BJC; Lambregts, MMC; Visser, LG | 1 |
| Hamilton, F; Laurenson, IF; Russell, CD; Templeton, K; Toner, G | 1 |
| Fu, Y; Ren, D; Yang, Q; Yao, Y; Yu, Y; Zhou, H; Zhou, J; Zhu, B | 1 |
| Chen, S; Deng, K; Du, X; Feng, G; Shen, Z; Xu, X; Yang, L; Yao, J | 1 |
| Charernmak, B; Chongsuvivatwong, V; Chusri, S; Doi, Y; Hortiwakul, T; Silpapojakul, K; Singkhamanan, K | 1 |
| Asch, J; Coombs, J; Ford, CD; Hoda, D; Lopansri, BK; Ostronoff, F; Stofer, MG; Webb, BJ | 1 |
| Bonomo, RA; Perez, F | 2 |
| Abi Hanna, P; Aliyu, S; Allignol, A; Alvarez-Moreno, C; Arora, A; Bagga, R; Barman, P; Bhattarai, B; Carvalho, MJ; Correa, AL; Delgado-Ramirez, MA; El-Banna, T; El-Bouseary, M; Feghali, R; Harbarth, S; Hassan, B; Iregbu, K; Kanj, SS; Kaur, A; Khanal, B; Le, TAT; Marimuthu, K; Munera, MI; Ovosi, JO; Owusu-Ofori, AK; Phukan, C; Saad, H; Saha, SK; Saleemi, MA; Sengupta, S; Sharma, L; Stewardson, AJ; Tran, TTN; Uddin, J; Uwaezuoke, NS; Valderrama-Beltrán, SL; Walsh, TR; Zahra, R | 1 |
| Al Amin, M; Al Busaidi, I; Al'Adawi, B; Al-Muharrmi, Z; Al-Siyabi, T; Balkhair, A; Hassan, KS; Taher, HB | 1 |
| Allou, N; Allyn, J; Aujoulat, T; Ferdynus, C; Lair, T; Lugagne, N; Miltgen, G; Teysseyre, L | 1 |
| Amadori, F; Bartoletti, M; Bassetti, M; Carannante, N; Ceccarelli, G; Corcione, S; De Rosa, FG; Del Bono, V; Di Caprio, G; Giacobbe, DR; Giannella, M; Granata, G; Losito, AR; Menichetti, F; Mussini, C; Peghin, M; Petrosillo, N; Russo, A; Santoro, A; Segala, FV; Tascini, C; Tumbarello, M; Vena, A; Venditti, M; Viale, P; Viscoli, C | 1 |
| Lai, RW; Leung, EC; Leung, PH | 1 |
| Bonomo, RA; Cober, E; Doi, Y; Evans, S; Fowler, VG; Harris, A; Henderson, H; Kalayjian, RC; Kaye, KS; Luterbach, CL; Napravnik, S; Richter, SS; Salata, RA; Van Duin, D; Watkins, RR | 1 |
| Antachopoulos, C; Darda, VM; Haidich, AB; Iosifidis, E; Roilides, E; Sdougka, M; Vagdatli, E; Volakli, E | 1 |
| Materne, M; Miyakis, S; Newton, P; Reynolds, G; Skyring, T; Trad, MA; Yao, J | 1 |
| Anandan, S; Babu, P; Jeyaseelan, V; Munusamy, E; Nabarro, LE; Ravi, R; Rupali, P; Shankar, C; Veeraraghavan, B; Verghese, VP | 1 |
| Chen, Y; Li, L; Violetta, L; Xiao, Y; Zheng, B | 1 |
| Hasan, MJ; Rabbani, R | 1 |
| Jeong, IS; Song, JY | 1 |
| Kaniga, K; Lee, M; Redman, R; Rice, DA | 1 |
| Baziaka, F; Galani, L; Giamarellou, H; Karaiskos, I | 1 |
| Al-Agamy, MH; Elkhizzi, NA; Livermore, DM; Meunier, D; Shibl, AM; Turton, JF | 1 |
| Caio, C; Ceccarelli, G; Falcone, M; Giordano, A; Mezzatesta, ML; Stefani, S; Venditti, M | 1 |
| Castanheira, M; Deshpande, LM; Farrell, SE; Jones, RN; Mendes, RE | 1 |
| Nanas, S; Papas, V; Pitsiolis, T; Platsouka, E; Pratikaki, M; Roussos, C; Routsi, C; Sotiropoulou, C; Tsakris, A | 1 |
| Ko, WC; Lee, JC; Lee, NY; Li, CW; Li, MC | 1 |
| Barth, AL; Hermes, DM; Lutz, L; Martins, AF; Netto, B; Pormann Pitt, C; Ribeiro, VB; Teixeira, AB; Zavascki, AP | 1 |
| Chung, EK; Jang, HC; Jang, MO; Jung, SI; Kang, SJ; Kim, SH; Ko, KS; Lee, SY; Park, KH; Shin, JH | 1 |
| Lastovetska, O; Low, DE; Macmullin, G; Melano, RG; Patel, SN; Stacey-Works, T; Tijet, N; Vermeiren, C; Wenzel, P | 1 |
| Hsueh, PR; Ko, WC; Lee, CC; Lee, NY; Li, CW | 1 |
| Aitken, SL; Altshuler, J; Arias, CA; Esaian, D; Guervil, D; Papadopoulos, J | 1 |
| Chang, FY; Chen, TL; Fung, CP; Kuo, SC; Lee, YT; Lin, JC; Sun, JR; Tsai, WC; Yang, CH; Yang, YS | 1 |
| Abdel-Massih, R; Bogdanovich, T; Chavda, KD; Chen, L; Cheng, S; Clancy, CJ; Doi, Y; Hao, B; Hong Nguyen, M; Hong, JH; Humar, A; Kreiswirth, BN; Kwak, EJ; Perlin, DS; Shields, RK; Silveira, FP; Zhao, Y | 1 |
| Giannella, M; Lewis, R; Petrosillo, N; Trecarichi, EM; Tumbarello, M; Viale, P | 1 |
| Falagas, ME; Lourida, P; Poulikakos, P; Rafailidis, PI; Tansarli, GS | 1 |
| Adams, BN; Lekovic, JP; Robinson, S | 1 |
| Chu, YZ; Deng, QL; Dong, F; Fu, WL; Hu, BJ; Hu, YJ; Hu, ZD; Ji, P; Jin, YF; Li, Y; Liu, WE; Lü, XJ; Lü, Y; Meng, L; Pan, SY; Pei, FY; Wang, S; Xu, XL; Xue, F; Yang, B; Yang, J; Yang, YJ; Yu, YS; Zhang, XZ; Zhao, JH; Zhao, WS; Zhou, L | 1 |
| Bodro, M; Boix, L; Calvo, M; Carratalà, J; Contra, A; Domingo-Domenech, E; Garcia-Vidal, C; Gudiol, C; Tubau, F | 1 |
| Deb, M; Gaind, R; Maurya, V; Mohanty, S | 1 |
| Andremont, A; Armand-Lefèvre, L; Birgand, G; Lolom, I; Lucet, JC; Neulier, C; Ruppé, É; Yazdanpanah, Y | 1 |
| Apisarnthanarak, A; Lye, DC; Ng, TM; Teng, CB | 1 |
| Chiang, MC; Chu, SM; Fu, RH; Hsu, JF; Huang, HR; Huang, YC; Lee, CW; Lien, R; Tsai, MH | 1 |
| D'Abramo, A; D'Agostino, C; Gallinelli, C; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Vullo, V | 1 |
| Agalar, C; Akalin, S; Alici, O; Alp, E; Altay, FA; Altin, N; Arslan, F; Aslan, T; Balkan, II; Batirel, A; Bekiroglu, N; Celik, AD; Cesur, S; Dogan, M; Durdu, B; Duygu, F; Engin, A; Engin, DO; Gonen, I; Guclu, E; Guven, T; Hatipoglu, CA; Hosoglu, S; Karabay, O; Karahocagil, MK; Kilic, AU; Ormen, B; Ozdemir, D; Ozer, S; Oztoprak, N; Sezak, N; Turhan, V; Turker, N; Yilmaz, H | 1 |
| Baghdady, N; Ferraro, MJ; Galar, A; Guzmán-Suarez, BB; Hooper, DC; Kubiak, DW; Marty, FM; O'Brien, TF; Siedner, MJ | 1 |
| Chang, SC; Chuang, YC; Huang, YS; Sheng, WH; Wang, JT | 1 |
| Chen, H; Liu, DW; Long, Y; Wang, XT; Zhang, HM | 1 |
| Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI | 1 |
| Braun, T; Carmeli, Y; Edgar, R; Glick, R; Hoshen, M; Nutman, A; Temkin, E | 1 |
| Falagas, ME; Karageorgopoulos, DE; Tansarli, GS; Vardakas, KZ | 1 |
| Aras, S; Aydın, S; Aygün, G; Balkan, II; Kara, Z; Kuşkucu, M; Mete, B; Midilli, K; Mutcalı, SI; Özaras, R; Öztürk, R; Saltoğlu, N; Şemen, V; Tabak, F; Yemişen, M | 1 |
| Axelrod, P; Gallagher, JC; Haynes, K; Kuriakose, S | 1 |
| Bae, IK; Jeong, SH; Jeong, SJ; Kim, JM; Lee, K; Yoon, SS | 1 |
| Kumar, A; Nirupam, N; Rai, Y; Randhawa, VS; Saili, A | 1 |
| Chen, YH; Chu, FY; Chuang, YC; Hsueh, PR; Huang, CC; Ko, WC; Liao, CH; Sheng, WH; Tang, HJ; Tsai, HY | 1 |
| Ali, S; Baqi, S; Kalam, K; Kumar, S; Qamar, F | 1 |
| Kollef, MH; Micek, ST; Shorr, AF; Zilberberg, MD | 1 |
| Li, J; Mukhopadhyay, A; Tambyah, PA; Vasudevan, A; Yuen, EG | 1 |
| Antoniadou, E; Antypa, E; Falagas, ME; Koteli, A; Matthaiou, DK; Vardakas, KZ | 1 |
| Fujimoto, Y; Ichiyama, S; Ito, Y; Machida, K; Matsumura, Y; Nagao, M; Ogawa, K; Okamoto, S; Takakura, S; Tanaka, M; Uemoto, S; Yamamoto, M; Yoshizawa, A | 1 |
| LaRosa, SP; McCrea, K; Ward, R | 1 |
| Andersson, R; Berge, J; Vandepitte, WP | 1 |
| Chen, L; Clancy, CJ; Clarke, LG; Eschenauer, GA; Kreiswirth, BN; Nguyen, MH; Potoski, BA; Press, EG; Shields, RK | 1 |
| Chen, TL; Chow, SF; Liu, CP; Shih, SC; Sun, FJ; Wang, NY; Wu, AY; Yan, TR | 1 |
| Avdic, E; Cosgrove, SE; Han, JH; Harris, AD; Hsu, AJ; Lautenbach, E; Rock, C; Tamma, PD | 1 |
| Dantas, RC; Faria, ALS; Ferreira, ML; Gonçalves, IR; Gontijo-Filho, PP; Queiroz, LL; Ribas, RM; Silveira de Brito, C | 1 |
| Asch, J; Bo Petersen, F; Burke, JP; Dascomb, KK; Ford, CD; Haydoura, S; Lopansri, BK; Snow, G | 1 |
| Edwards, JR; Fridkin, SK; Magill, SS; Ricks, PM; Sievert, DM; Soe, MM | 1 |
| Amit, S; Carmeli, Y; Kotlovsky, T; Mishali, H; Schwaber, MJ | 1 |
| Ambretti, S; Bartoletti, M; Callea, E; Cavalli, M; Cristini, F; De Palma, A; Giannella, M; Gibertoni, C; Lewis, RE; Masina, R; Moro, ML; Mosci, D; Puggioli, MC; Tedeschi, S; Tumietto, F; Venturi, S; Viale, P | 1 |
| Augustine, JJ; Bonomo, RA; Hujer, AM; Jacobs, GH; Jacobs, MR; Patel, G; Perez, F; Rudin, SD | 1 |
| Carmeli, Y; Costa, AN; Grossi, PA; Ippolito, G; Ison, MG; Lanini, S; Procaccio, F; Puro, V; Ricci, A; Vesconi, S; Vespasiano, F | 1 |
| Bass, SN; Bauer, SR; Lam, SW; Neuner, EA | 1 |
| Amaya-Villar, R; Díaz-Martín, A; Ferrándiz-Millón, C; Garnacho-Montero, J; Gutiérrez-Pizarraya, A; López-Sánchez, JM | 1 |
| Angebault, C; Bourhis, JH; Chachaty, E; de Botton, S; Gachot, B; Micol, JB; Pasquier, F; Pilorge, S; Woerther, PL | 1 |
| Azouri, T; Bathina, P; Kandipalli, D; Kaplansky, T; Kaye, KS; Lazarovitch, T; Marchaim, D; Maskit, M; Ofer-Friedman, H; Sharma, S; Shefler, C; Tal-Jasper, R; Tirosh, A; Zaidenstein, R | 1 |
| Hiraki, K; Murakami, N; Sugawara, T; Uetake, N | 1 |
| Guo, W; Li, J; Shan, K; Xu, B | 1 |
| Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ | 1 |
| Andria, N; Domchenko, A; Fraser, D; Henig, O; Kotler, O; Ofran, Y; Oren, I; Paul, M; Zuckerman, T | 1 |
| Cakirlar, FK; Ciftci, IH; Gonullu, N | 1 |
| Abe, H; Arita, M; Kamimura, K; Kawai, H; Kobayashi, M; Kobayashi, Y; Kumaki, D; Kusama, F; Mizuno, K; Ogawa, K; Sato, Y; Shinagawa, Y; Takahashi, Y; Takeuchi, M; Terai, S; Yamagiwa, S | 1 |
| Kollef, MH; Shorr, AF; Zilberberg, MD | 1 |
| Abbo, LM; Aragon, L; Beduschi, T; Camargo, JF; Cantón, R; Morris, MI; Pérez-Cardona, A; Prado, CE; Simkins, J; Tekin, A | 1 |
| Chen, FJ; Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF | 1 |
| Chang, CM; Chen, PL; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC | 1 |
| Hsueh, PR; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC; Lo, CL | 1 |
| Alicino, C; Copello, F; Del Bono, V; Giacobbe, DR; Icardi, G; Orsi, A; Sarteschi, G; Tassinari, F; Trucchi, C; Viscoli, C | 1 |
| Meng, DY; Xue, WC; Zhang, LP | 1 |
| Bass, SN; Bauer, SR; Gibson, GA; Lam, SW; Neuner, EA | 1 |
| Abdile, AA; Doi, Y; Harris, PN; Huh, K; Huxley, RR; O'Neal, CS; Pandeya, N; Paterson, DL; Paynter, S; Shen, AW; Talbot, TR; Wei, JY | 1 |
| Cprek, JB; Gallagher, JC | 1 |
| Feng, Y; Huang, L; Wang, X; Xie, L; Xie, Y; Zong, Z | 1 |
| Biehle, LR; Cottreau, JM; Filipek, RL; Hirsch, EB; Lasco, TM; Mahoney, MV; O'Donnell, JN; Thompson, DJ | 1 |
| Cao, B; Chen, H; Chen, X; Chu, Y; Guo, P; Hu, B; Hu, Z; Jin, Y; Liao, K; Liu, W; Liu, Y; Luo, Y; Su, D; Tian, B; Wang, H; Wang, Y; Wang, Z; Xu, X; Zeng, J; Zhang, F; Zhang, R; Zhao, C; Zhou, C; Zhou, H; Zhuo, C; Zou, M | 1 |
| Kamath, S; M Shenoy, S; Sinha, R | 1 |
| Jeon, H; Kang, HY; Kim, BR; Kim, CH; Lee, JC; Lee, SH; Lee, YC | 1 |
| Shah, PG; Shah, SR | 1 |
| Rodrigues, C; Shetty, A; Soman, R | 1 |
| Firouzi, R; Pouladfar, G; Pourabbas, B | 1 |
| Hata, K; Ichiyama, S; Iida, T; Kaido, T; Okajima, H; Sato, A; Takakura, S; Uemoto, S; Yagi, S | 1 |
| Dong, F; Guo, L; Li, S; Liu, G; Liu, L | 1 |
| Cipolla, A; D'Abramo, A; De Angelis, M; Favaro, M; Ferretti, G; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Vullo, V | 1 |
| Clancy, CJ; Nguyen, MH; Press, EG; Shields, RK | 1 |
| Chen, XL; Huang, AW; Liu, SL; Liu, WJ; Lu, XZ; Zhang, N; Zhang, Y | 1 |
| Hallböök, H; Lidström, AK; Pauksens, K | 1 |
| Chow, A; De, PP; Harris, PN; Khong, WX; Lye, DC; Ng, TM; Tambyah, PA | 1 |
| Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; de Cueto, M; Gasch, O; Giamarellou, H; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hernández, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Molina, J; Mora-Rillo, M; Natera, C; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pérez-Galera, S; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Salamanca, E; Schwaber, MJ; Souli, M; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, P | 1 |
| Altindis, M; Demiray, T; Koroglu, M; Ozbek, A | 1 |
| Dowzicky, MJ; Rodloff, AC | 1 |
| Fransén, J; Hanberger, H; Huss, FR; Nilsson, LE; Rydell, U; Sjöberg, F | 1 |
| Chen, YB; Huang, JA; Zhang, M | 1 |
| Ayora, M; Famiglietti, Á; García, S; Nastro, M; Rodriguez, CH; Vay, C | 1 |
| Fujiya, Y; Hayakawa, K; Kutsuna, S; Mawatari, M; Mezaki, K; Nagamatsu, M; Ohmagari, N; Takeshita, N; Tamura, S; Yamamoto, K | 1 |
| Askin, G; Chen, L; Cohen, N; Gedrimaite, Z; Kreiswirth, BN; Ma, KC; Satlin, MJ; Seo, SK; Soave, R; Walsh, TJ | 1 |
| Aversa, F; Busca, A; Candoni, A; Cattaneo, C; Del Principe, MI; Delia, M; Di Blasi, R; Fanci, R; Fianchi, L; Lessi, F; Martino, B; Melillo, L; Nadali, G; Pagano, L; Perriello, V; Sica, S; Trecarichi, EM; Tumbarello, M | 1 |
| Ashok, A; Das, BR; Dey, S; Gandra, S; Klein, EY; Kumari, M; Laxminarayan, R; Mojica, N; Nerurkar, V; Ramesh, U; Vadwai, V | 1 |
| Altunçekiç Yıldırım, A; Çalgın, MK; Çetinkol, Y; Telli, M | 1 |
| Fukuchi, T; Iwata, K; Kobayashi, S; Nakamura, T; Ohji, G | 1 |
| Jiménez, JN; Parra, OL; Vanegas, JM | 1 |
| Álvarez, C; Ardila, N; Ariza, B; Caro, MA; Gil, F; González, PF; Valderrama, SL | 1 |
| Chen, TL; Chiang, MC; Kuo, SC; Lee, IH; Lee, YT; Wang, YC; Yang, YS | 1 |
| Mikamo, H; Sugimoto, N; Yamagishi, Y | 1 |
| Buehrle, DJ; Clancy, CJ; Clarke, LG; Nguyen, MH; Potoski, BA; Shields, RK | 1 |
| Eng, LC; Kwang, LL; Ng, LS; Rao, S; Tan, TY | 1 |
| Ambretti, S; Bruzzi, P; Cardellino, CS; Coppo, E; Corcione, S; De Rosa, FG; Del Bono, V; Giacobbe, DR; Giannella, M; Magnasco, L; Maraolo, AE; Marchese, A; Pagani, N; Saffioti, C; Viale, P; Viscoli, C | 1 |
| Aslam, S; Kotton, CN; Kumar, D; Logan, C; Mehta, SR | 1 |
| Álvarez-Marín, R; Aznar, J; Cisneros, JM; Garnacho-Montero, J; Gómez, MJ; López-Rojas, R; Márquez, JA; Molina, J; Ortiz-Leyba, C; Pachón, J | 1 |
| Harris, PN; Lane, SW; Liborio, M; Paterson, DL; Peri, AM; Righi, E; Wailan, AM | 1 |
| Jeyaseelan, V; Mathew, G; Nabarro, LEB; Pragasam, AK; Shankar, C; Veeraraghavan, B; Verghese, VP | 1 |
| Goodman, KE; Harris, AD; Roberts, A; Simner, PJ; Taiwo, A; Tamma, PD; Tekle, T | 1 |
| Moy, S; Sharma, R | 1 |
| Aykac, K; Basaranoglu, ST; Cengiz, AB; Ceyhan, M; Kara, A; Karahan, S; Ozsurekci, Y; Sancak, B | 1 |
| Chen, L; DeLeo, FR; Dorward, DW; Freedman, B; Kobayashi, SD; Kreiswirth, BN; Porter, AR | 1 |
| Falgenhauer, L; Fuchs, K; Gerlach, RG; Gessner, A; Hiergeist, A; Jantsch, J; Melzl, H; Pfeifer, Y; Reischl, U; Richert, K; Simon, M | 1 |
| Barmpouti, E; Galani, L; Giamarellou, H; Karaiskos, I; Masgala, A; Souli, M | 1 |
| Ballarò, D; Bucaneve, G; Capria, S; Cartoni, C; Foà, R; Gentile, G; Grammatico, S; Micozzi, A; Minotti, C; Pacetti, E; Santilli, S | 1 |
| Adil, S; Habib, F; Hasan, R; Idrees, F; Irfan, S; Mehraj, V | 1 |
| Apisarnthanarak, A; Kiratisin, P; Mundy, LM | 1 |
| Basso, M; Costa, SF; Gobara, S; Gomez, LB; Levin, AS; Oshiro, I; Paez, JG; Spadão, F | 1 |
| Hiraoka, A; Karasuno, T; Kiyomizu, K; Minami, R; Tanimura, A; Yagi, T; Yoshida, H | 1 |
| Dropa, M; Elmor de Araújo, MR; Grinbaum, RS; Lincopan, N; Mamizuka, EM; Matté, MH; Neves, P; Pavez, M | 1 |
| Dunne, WM; Fraser, VJ; Frye, JG; Marschall, J; Tibbetts, RJ; Warren, DK | 1 |
| Aggarwal, P; Capoor, MR; Deb, M; Nair, D; Pillai, P; Posti, J; Singhal, S | 1 |
| Bamia, C; Daikos, GL; Georgousi, K; Kosmidis, C; Petrikkos, G; Petrikkos, P; Psichogiou, M; Skoutelis, A; Tassios, PT; Tzouvelekis, LS; Vryonis, E | 1 |
| Apisarnthanarak, A; Kiratisin, P; Laowansiri, P; Shah, S | 1 |
| Khan, L; Nadkarni, AS; Schliep, T; Zeana, CB | 1 |
| Biek, D; Janes, R; Morrissey, I | 1 |
| Choe, KW; Jang, HC; Jeon, JH; Kim, CJ; Kim, EC; Kim, HB; Kim, KH; Kim, NJ; Kim, SH; Lee, S; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
| Amicosante, G; Falcone, M; Mancini, C; Mezzatesta, ML; Perilli, M; Stefani, S; Venditti, M | 1 |
| Donaldson, AD; Fisher, DA; Liang, LJ; Razak, L; Tambyah, PA | 1 |
| Gordon, NC; Wareham, DW | 1 |
| Borer, A; Eskira, S; Nativ, R; Peled, N; Riesenberg, K; Saidel-Odes, L; Schlaeffer, F; Sherf, M | 1 |
| Ariza, J; Dominguez, MA; Gavaldà, L; Gudiol, F; Manzur, A; Peña, C; Pujol, M; Suárez, C; Tubau, F | 1 |
| Giamarellou, H; Markaki, V; Nanas, S; Paniara, O; Platsouka, E; Pratikaki, M; Roussos, C; Routsi, C; Sotiropoulou, C; Vrettou, C | 1 |
| Bryan, M; Della-Latta, P; Eschenauer, GA; Furuya, EY; Kubin, CJ; Nguyen, M; O'Neil, K | 1 |
| Chang, CM; Chen, PL; Chi, CH; Ko, NY; Ko, WC; Lee, CC; Lee, HC; Lee, NY; Wang, LR; Wu, CJ; Yan, JJ | 1 |
| Cacciarelli, TV; Muder, RR; Shields, RK; Singh, N; Sun, HY | 1 |
| Chang, SC; Chen, YS; Hsu, LY; Hsu, MS; Ko, WC; Lau, YJ; Lauderdale, TL; Liao, CH; Lin, SY; Liu, JW; Liu, KS; Sheng, WH; Tsai, TY; Wang, LH | 1 |
| Baig, M; Lavin, MA; Mohapatra, S; Munoz-Price, LS; Penugonda, S; Quinn, JP; Schreckenberger, P; Vais, D; Weinstein, RA; Welbel, S; Zembower, T | 1 |
| Basu, S; Das, P; Roy, S; Singh, A; Viswanathan, R | 1 |
| Ishiyama, K; Nakao, S; Senda, Y; Yamauchi, H; Yamazaki, H | 1 |
| Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF | 1 |
| Ko, KS; Lee, H; Peck, KR; Song, JH | 1 |
| Giasnetsova, T; Gritsi-Gerogianni, N; Iosifidis, E; Karapanagiotou, A; Mouloudi, E; Protonotariou, E; Roilides, E; Sofianou, D; Tsioka, A; Zagorianou, A | 1 |
| Benyamini, N; Fineman, R; Finkelstein, R; Oren, I; Rowe, JM; Sprecher, H; Zuckerman, T | 1 |
| Cheong, HJ; Choi, WS; Heo, JY; Kim, WJ; Noh, JY; Song, JY | 1 |
| Arend, LN; Levin, AS; Penteado-Filho, SR; Pilonetto, M; Rymsza, AM; Tuon, FF | 1 |
| Bonomo, RA; Endimiani, A; Fraser, TG; Hall, GS; Neuner, EA; Sekeres, J; Shrestha, NK; van Duin, D; Yeh, JY | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC | 1 |
| Chang, HJ; Chia, JH; Hsu, PC; Kuo, AJ; Lee, MH; Wu, TL; Yang, CC | 1 |
| Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN | 1 |
| Anunnatsiri, S; Tonsawan, P | 1 |
| Cavalcante, AC; Furtado, GH; Gales, AC; Girardelo, R; Medeiros, EA; Oliveira, VG | 1 |
| Esterly, JS; Griffith, M; Malczynski, M; Postelnick, MJ; Qi, C; Scheetz, MH | 1 |
| Choi, JY; Jung, SI; Kim, DH; Kim, SH; Ko, KS; Park, KH; Park, YK | 1 |
| Jung, SI; Kim, SH; Ko, KS; Park, KH; Park, YK | 1 |
| Chang, SC; Chen, WC; Chen, YC; Hu, FC; Wang, JL; Wu, UI; Yang, CS | 1 |
| Chen, CP; Chen, TL; Chiang, MC; Fung, CP; Kuo, SC; Lee, YT; Yang, SP | 1 |
| Canteras, M; García-Vázquez, E; Gómez, J; Hernández-Torres, A; Ruiz, J; Yagüe, G | 1 |
| Aguilar, M; Almirante, B; Calbo, E; Gozalo, M; Granados, A; Martínez-Martínez, L; Murillas, J; Oliver, A; Peña, C; Pomar, V; Rodríguez, F; Rodríguez-Baño, J; Suarez, C; Tubau, F | 1 |
| Boasquevisque, CH; Costa, LD; de Freitas, WV; de Matos, JA; de Souza, TC; Dias, RC; Girão, VB; Magalhães, AC; Martins, IS; Martins, N; Moreira, BM; Nouér, SA; Pellegrino, FL; Riley, LW; Santoro-Lopes, G | 1 |
| Bishara, J; Cohen, J; Goldberg, E; Lev, S; Singer, P | 1 |
| Decker-Burgard, S; Laeuffer, J; Morrissey, I; Mutters, R; Seifert, H; Valenza, G | 1 |
| Ko, WC; Lee, NY; Lin, SH; Tsai, LH; Wu, JJ; Yan, JJ | 1 |
| Cabot, G; Domínguez, MA; Macia, MD; Martínez-Martínez, L; Moncalián, G; Moya, B; Ocampo-Sosa, AA; Oliver, A; Peña, C; Rodríguez, C; Roman, E; Suárez, C; Tubau, F; Zamorano, L | 1 |
| Cheong, HS; Chung, DR; Kang, CI; Ko, KS; Peck, KR; Song, JH | 1 |
| Edmond, MB; Fehlberg, LC; Gales, AC; Marra, AR; Peraro, PP; Xavier, DE | 1 |
| Costa, SF; Levin, AS; Mostachio, AK; Rizek, C; Rossi, F; Zerbini, J | 1 |
| Cheng, A; Hsueh, PR; Huang, YT; Lee, YC; Liao, CH; Liu, CY; Tsai, HY | 1 |
| Chen, TL; Chiang, MC; Chiang, TH; Fung, CP; Huang, ST; Kuo, SC; Lee, YT; Yang, SP | 1 |
| Horowitz, A; Muchtar, E; Paul, M; Raanani, P; Shpilberg, O | 1 |
| Esterly, JS; McLaughlin, MM; Postelnick, MJ; Qi, C; Scheetz, MH; Wagner, J | 1 |
| Chang, J; Chung, KS; Jung, JY; Kang, YA; Kim, EY; Kim, SK; Kim, SY; Kim, YS; Lee, SK; Lim, JE; Park, BH; Park, MS; Park, SC | 1 |
| Nithitamsakun, N; Punpanich, W; Suntarattiwong, P; Treeratweeraphong, V | 1 |
| Calfee, DP; Chen, L; Fauntleroy, KA; Feldman, EJ; Helfgott, DC; Jenkins, SG; Kreiswirth, BN; Roboz, GJ; Satlin, MJ; Shore, TB; Soave, R; Walsh, TJ; Wilson, SJ | 1 |
| Apisarnthanarak, A; Chanvitan, P; Dissaneevate, S; Janjindamai, W; Maneenil, G; Thatrimontrichai, A | 1 |
| Abreu-Lanfranco, O; Chopra, T; Collins, V; Hayakawa, K; Kaye, KS; Lephart, PR; Marchaim, D; Martin, ET; Pogue, JM; Tansek, R | 1 |
| Chen, CH; Chen, JB; Chuang, FR; Lee, CH; Lee, CT; Li, SH; Wu, CH; Yang, CC | 1 |
| Chen, HM; Ko, WC; Lee, NY; Tsai, LH; Wang, MC; Wu, JJ; Yan, JJ | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC | 1 |
| Chan, JF; Cheng, VC; Ho, PL; Lo, WU; To, KK; Tse, H | 1 |
| Chang, SC; Dong, SX; Wang, JT | 1 |
| Chai, LY; Chee, YL; Chng, WJ; Ding, Y; Hsu, LY; Jin, J; Lee, YM; Poon, LM; Tan, LK | 1 |
| Burgess, DS; Lee, GC | 1 |
| Finkelstein, R; Hussein, K; Kassis, I; Neuberger, A; Oren, I; Raz-Pasteur, A; Shachor-Meyouhas, Y | 1 |
| Goldstein, EJ | 1 |
| Patterson, JE | 1 |
| Matsuda, H; Miwa, H; Miyazaki, S; Tsuji, M | 1 |
| Oishi, K | 1 |
| Huang, ST; Ko, WC; Lee, HC; Lee, NY; Liu, KH; Yan, JJ | 1 |
| Gales, AC; Reis, AO; Sader, HS; Silbert, S | 1 |
| Chang, LY; Hsueh, PR; Huang, LM; Lee, CY; Lee, PI; Lu, CY; Shao, PL; Wang, CY; Wu, TZ; Yang, CY | 1 |
| Cakir, B; Hascelik, G; Metan, G; Uzun, O; Zarakolu, P | 1 |
| Kobayashi, Y | 1 |
| Cal, RG; Castelo, A; do Carmo Filho, JR; Marra, AR; Pereira, CA; Sader, HS; Wey, SB | 1 |
| Endo, S; Hakozaki, M; Kojika, M; Sato, N; Suzuki, K; Suzuki, Y; Takahasi, G; Wakabayasi, G | 1 |
| Falagas, ME; Koletsi, PK; Kopterides, P; Michalopoulos, A | 2 |
| Bell, JM; Franklin, C; Peleg, AY; Spelman, DW | 1 |
| Aguilar, J; Almela, M; Balasso, V; López, F; Marco, F; Martínez, JA; Mensa, J; Pozo, L; Soriano, A | 1 |
| Lee, CH; Liu, JW; Su, LH; Tang, YF | 1 |
| Dahal, RK; Khadga, PK; Koirala, J; Mishra, SK; Pokharel, BM; Tuladhar, NR | 1 |
| Archontoulis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Mega, A; Pavleas, I; Rigas, K; Thomopoulos, G; Vernikos, P | 1 |
| Huang, SS; Lee, MH; Leu, HS | 1 |
| Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK | 1 |
| Aisenberg, G; Dickey, BF; Kontoyiannis, DP; Raad, II; Rolston, KV; Safdar, A | 1 |
| Chang, CY; Chang, YL; Hsu, CK; Hsueh, PR; Kuo, LC; Lai, CC; Liao, CH | 1 |
| Araujo, VR; Carvalho-Dias, VM; Cunha, CA; de Souza, CA; de Souza, M; Godoy, C; Lotfi, CJ; Maiolino, A; Nucci, M; Oliveira, AL; Pasquini, R; Ruiz, MA; Seber, A; Silla, L; Simões, BP; Tanaka, PY; Trabasso, P; Urakawa, P; Zanichelli, MA | 1 |
| Chang, KT; Garey, KW; LaRocco, MT; McCauley, SK; Poole, K; Schilling, AN; Tam, VH | 1 |
| Chin, BS; Choi, HK; Choi, JY; Choi, SH; Han, SH; Jeoung, SJ; Kim, CK; Kim, CO; Kim, JM; Kim, MS; Kim, YA; Lee, HS; Lee, K; Song, YG; Yong, D; Yum, JH | 1 |
| Chemaly, RF; Ghanem, G; Hachem, R; Jiang, Y; Raad, I | 1 |
| Borgianni, L; Cagnacci, S; Centanaro, M; Debbia, E; Docquier, JD; Dodi, F; Gualco, L; Mannelli, S; Marchese, A; Rossolini, GM; Roveta, S | 1 |
| Jayashree, M; Mathew, JL; Ray, P; Singhi, S | 1 |
| Grausova, S; Koren, P; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Lacka, J; Spanik, S; Trupl, J | 1 |
| Keil, S; Wiedemann, B | 1 |
| Mokaddas, EM; Sanyal, SC | 1 |
| Bryant, RE; Kohlhepp, SJ; Meyer, MM; Munar, MY | 1 |
| Akova, M; Gür, D; Kocagöz, S; Köseoğlu , O | 1 |
| Beloborodov, VB | 1 |
21 review(s) available for carbapenems and Bacteremia
| Article | Year |
|---|---|
Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Lactams; Randomized Controlled Trials as Topic; Sepsis | 2023 |
Health outcomes attributable to carbapenemase-producing Enterobacteriaceae infections: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospital Mortality; Humans; Length of Stay | 2020 |
Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftriaxone; Cephalosporin Resistance; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Randomized Controlled Trials as Topic | 2020 |
Pediatric Blood Cultures and Antibiotic Resistance: An Overview.
Topics: Anti-Bacterial Agents; Bacteremia; Blood Culture; Candida; Carbapenems; Child; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; India; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Salmonella; Typhoid Fever | 2020 |
Non-carbapenem β-lactam/β-lactamase inhibitors versus carbapenems for urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: a systematic review.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Urinary Tract Infections | 2021 |
Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Combinations; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Minocycline; Pneumonia; Polymyxin B; Polymyxins; Tigecycline; Treatment Outcome; Urinary Tract Infections | 2017 |
Antimicrobial Resistance of Hypervirulent
Topics: Bacteremia; Bacterial Capsules; Bacterial Proteins; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Hydroxamic Acids; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Molecular Epidemiology; Phylogeography; Serogroup; Urinary Tract Infections; Virulence; Virulence Factors | 2017 |
Is It Time to Rethink the Notion of Carbapenem-Sparing Therapy Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections? A Critical Review.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefepime; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans | 2018 |
Clinical effectiveness of carbapenems versus alternative antibiotics for treating ESBL-producing Enterobacteriaceae bacteraemia: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Sepsis; Treatment Outcome | 2018 |
Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Clinical Decision Rules; Female; Humans; Male; Pneumonia, Bacterial; Risk Factors | 2019 |
Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Models, Statistical; Risk Factors; Survival Analysis; Treatment Outcome | 2013 |
Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Critical Illness; Drug Therapy, Combination; Enterobacteriaceae; Humans; Minocycline; Pneumonia, Bacterial; Survival Analysis; Tigecycline; Urinary Tract Infections | 2014 |
Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxins; Sulbactam; Tigecycline | 2015 |
First case of bacteremia caused by Helicobacter cinaedi in a patient with liver cirrhosis: a case report and literature review.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Helicobacter; Helicobacter Infections; Humans; Immunocompromised Host; Liver Cirrhosis; Male | 2015 |
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Enterobacteriaceae Infections; Humans; Quinolones; Serratia Infections; Survival Analysis; Treatment Outcome | 2016 |
Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Odds Ratio; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors | 2016 |
Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.
Topics: Acinetobacter; Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Drug Resistance, Bacterial; Female; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Israel; Italy; Klebsiella; Klebsiella Infections; Male; Middle Aged; Neutropenia; Prevalence; Pseudomonas | 2017 |
Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Combinations; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Polymyxins; Tigecycline; Treatment Outcome | 2012 |
Extended spectrum beta-lactamases: a therapeutic dilemma.
Topics: Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Prognosis; Risk Assessment; Risk Factors; Treatment Outcome | 2002 |
[Pseudomonas aeruginosa infection].
Topics: 4-Quinolones; Anti-Infective Agents; Bacteremia; Biofilms; Carbapenems; Cephalosporins; Fimbriae, Bacterial; Flagella; Humans; Immunocompromised Host; Multidrug Resistance-Associated Proteins; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Trans-Activators; Urinary Tract Infections | 2003 |
[A choice of antibacterial chemotherapy for nosocomial infections caused by pathogens producing broad-spectrum beta-lactamases].
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cross Infection; Humans | 2001 |
10 trial(s) available for carbapenems and Bacteremia
| Article | Year |
|---|---|
Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Carbapenems; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neutropenia; Research; Treatment Outcome | 2022 |
Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Piperacillin, Tazobactam Drug Combination; Treatment Outcome | 2022 |
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sepsis; Urinary Tract Infections; Young Adult | 2021 |
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections | 2013 |
Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; DNA, Bacterial; Female; Follow-Up Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Organ Transplantation; Polymerase Chain Reaction; Prognosis; Retrospective Studies; Risk Factors; Survival Rate | 2013 |
Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin.
Topics: Acinetobacter baumannii; Adult; Bacteremia; Carbapenems; Colistin; Disease-Free Survival; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Humans; Male; Pneumonia, Ventilator-Associated; Prospective Studies; Survival Rate | 2016 |
Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Therapy, Combination; Humans; Korea; Linezolid; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Salvage Therapy; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2009 |
Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunocompromised Host; Intensive Care Units; Male; Middle Aged; Odds Ratio; Renal Insufficiency; Retrospective Studies; Risk Factors; Survival Rate; Time Factors | 2012 |
[A preliminary study of the administration of carbapenem antibiotics in sepsis patients on the basis of the administration time].
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Carbapenems; Drug Administration Schedule; Female; Humans; Male; Meropenem; Middle Aged; Thienamycins | 2005 |
Impact of carbapenem administration on systemic endotoxemia in patients with severe sepsis and Gram-negative bacteremia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxemia; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Sepsis | 2006 |
391 other study(ies) available for carbapenems and Bacteremia
| Article | Year |
|---|---|
Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Adult; Aged; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Lactams; Male; Middle Aged; Retrospective Studies | 2021 |
The investigation of adrenal involvement in carbapenem resistant Acinetobacter baumannii sepsis: experimental mouse model
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adrenal Insufficiency; Animals; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Corticosterone; Female; Mice; Microbial Sensitivity Tests; Sepsis | 2021 |
Antimicrobial treatment of monomicrobial phenotypic carbapenem-resistant Klebsiella pneumoniae bacteremia: Two are better than one.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies | 2022 |
Risk factors for bloodstream infection by multidrug-resistant organisms in critically ill patients in a reference trauma hospital.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Critical Illness; Drug Resistance, Multiple, Bacterial; Enterococcus; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Risk Factors; Sepsis | 2022 |
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prospective Studies; Respiratory Sounds | 2022 |
Trends in antimicrobial resistance in bloodstream infections at a large tertiary-care hospital in China: a 10-year retrospective study (2010-2019).
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers | 2022 |
Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Risk Factors | 2022 |
Antimicrobial stewardship programme associated with earlier prescription of in vitro susceptible therapy and lower 14-day mortality in patients with carbapenem-resistant Enterobacterales bacteraemia: a cohort study.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Gammaproteobacteria; Humans; Prescriptions; Retrospective Studies; Shock, Septic | 2022 |
Central-line-associated bloodstream infections, multi-drug-resistant bacteraemias and infection control interventions: a 6-year time-series analysis in a tertiary care hospital in Greece.
Topics: Adult; Bacteremia; Carbapenems; Catheter-Related Infections; Cross Infection; Disinfectants; Greece; Humans; Incidence; Infection Control; Intensive Care Units; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Tertiary Care Centers | 2022 |
Adipose tissue is a predictor of 30-days mortality in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae.
Topics: Adipose Tissue; Anti-Bacterial Agents; Bacteremia; Carbapenems; COVID-19; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; SARS-CoV-2; Sepsis | 2022 |
Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Incidence, etiology, risk factors, and outcomes of pre-engraftment bloodstream infections after first and second allogeneic hematopoietic cell transplantation.
Topics: Bacteremia; Bacteria; Carbapenems; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Retrospective Studies; Risk Factors; Sepsis | 2022 |
Rapid Diagnostics for Antibiotic Resistance: Urgent Need for Strong Clinical Evidence.
Topics: Bacteremia; Carbapenems; Drug Resistance, Microbial; Humans; Klebsiella pneumoniae; Rapid Diagnostic Tests | 2022 |
Impact of a Rapid Molecular Test for Klebsiella pneumoniae Carbapenemase and Ceftazidime-Avibactam Use on Outcomes After Bacteremia Caused by Carbapenem-Resistant Enterobacterales.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Nosocomial transmission and rearrangement of large resistance-virulence hybrid plasmids between two bacteremic ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae strains with low fitness cost.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Virulence | 2022 |
Different clinical characteristics and impact of carbapenem-resistance on outcomes between Acinetobacter baumannii and Pseudomonas aeruginosa bacteraemia: a prospective observational study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Retrospective Studies | 2022 |
Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Female; Healthcare-Associated Pneumonia; Humans; Male; Middle Aged; Molecular Epidemiology; Prospective Studies; Saudi Arabia | 2022 |
Thirty-Day Mortality Rates in Patients with Extended-Spectrum β-Lactamase-Producing
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Ertapenem; Escherichia coli; Humans; Klebsiella pneumoniae; Retrospective Studies | 2022 |
Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Biliary Tract; Carbapenems; Cholangiocarcinoma; Cholangitis; Cohort Studies; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Renal Insufficiency, Chronic; Risk Factors | 2022 |
Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Humans; Hypertension; Klebsiella Infections; Klebsiella pneumoniae; Longitudinal Studies; Retrospective Studies; Risk Factors; Sepsis | 2022 |
Six-Year Time-Series Data on Multidrug-Resistant Bacteremia, Antibiotic Consumption, and Infection Control Interventions in a Hospital.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies | 2022 |
Clinical Outcomes and Risk Factors for Carbapenem-resistant Enterobacterales Bloodstream Infection in Solid Organ Transplant Recipients.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Humans; Liver Transplantation; Retrospective Studies; Risk Factors; Sepsis; Transplant Recipients | 2023 |
High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Edetic Acid; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Prevalence | 2022 |
Pseudomonas putida bacteremia in pediatric patients: A case series study.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Humans; Pseudomonas putida; Retrospective Studies | 2023 |
Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Humans; Microbial Sensitivity Tests; Risk Factors | 2022 |
Double-, single- and none-carbapenem-containing regimens for the treatment of carbapenem-resistant Enterobacterales (CRE) bloodstream infections: a retrospective cohort.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Humans; Retrospective Studies; Sepsis | 2022 |
Lipocalin-2 is an essential component of the innate immune response to Acinetobacter baumannii infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacteremia; Carbapenems; COVID-19; Humans; Immunity, Innate; Iron; Lipocalin-2; Mice; Pandemics; Pneumonia, Bacterial; Siderophores | 2022 |
Human Cell-Camouflaged Nanomagnetic Scavengers Restore Immune Homeostasis in a Rodent Model with Bacteremia.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; COVID-19 Drug Treatment; Cytokines; Endotoxins; Escherichia coli; Escherichia coli Infections; Glycophorins; Homeostasis; Humans; Microbial Sensitivity Tests; Opsonin Proteins; Rats; Receptors, Complement; Rodentia; SARS-CoV-2; Viral Envelope Proteins | 2022 |
Epidemiology, aetiology and clinical characteristics of clostridial bacteraemia: a 6-year population-based observational study of 386 patients.
Topics: Aged; Bacteremia; C-Reactive Protein; Carbapenems; Clostridium; Clostridium Infections; Female; Humans; Male; Metronidazole; Retrospective Studies | 2022 |
Biofilm formation is not an independent risk factor for mortality in patients with
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Biofilms; Carbapenems; Heart Failure; Humans; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors | 2022 |
Bloodstream infections and antibiotic resistance patterns: a six-year surveillance study from southern Italy.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Humans; Italy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Sepsis | 2023 |
Carbapenem-resistant Enterobacterales in patients with bacteraemia at tertiary academic hospitals in South Africa, 2019 - 2020: An update.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; Colistin; Female; Humans; Infant; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; South Africa; Tertiary Care Centers; Young Adult | 2022 |
Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Humans; Retrospective Studies | 2023 |
Clinical characteristics and outcomes of carbapenem-resistant Enterobacterales bacteremia in pediatric patients.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Child; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Retrospective Studies | 2023 |
Initial empirical antibiotics of non-carbapenems for ESBL-producing E. coli and K. pneumoniae bacteremia in children: a retrospective medical record review.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Child; Child, Preschool; Escherichia coli; Humans; Klebsiella pneumoniae; Medical Records; Retrospective Studies | 2022 |
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pneumonia; Urinary Tract Infections | 2023 |
Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study.
Topics: Bacteremia; Carbapenems; Ceftazidime; Hematologic Neoplasms; Humans; Prospective Studies; Retrospective Studies | 2022 |
Within-Host Genotypic and Phenotypic Diversity of Contemporaneous Carbapenem-Resistant Klebsiella pneumoniae from Blood Cultures of Patients with Bacteremia.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Sepsis | 2022 |
Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort study.
Topics: Adult; Anti-Infective Agents; Bacteremia; Carbapenems; Humans; Neutropenia; Pseudomonas aeruginosa; Retrospective Studies; Sepsis | 2022 |
Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
Topics: Adult; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Hematologic Neoplasms; Humans; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Sepsis; Shock, Septic; Tertiary Care Centers | 2022 |
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Carbapenems; Cohort Studies; Cross Infection; Escherichia coli; Hospitals; Humans; Intensive Care Units; Prospective Studies | 2023 |
Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapy.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Humans; Neutropenia; Retrospective Studies; Shock, Septic | 2023 |
Risk Factors for Infection and Mortality Associated With Stenotrophomonas maltophilia Bloodstream Infections in Children; Comparison With Pseudomonas aeruginosa Bloodstream Infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Gram-Negative Bacterial Infections; Humans; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Sepsis; Stenotrophomonas maltophilia | 2023 |
Clinical impact and early prediction of carbapenem-resistant Pseudomonas aeruginosa bacteraemia in allogeneic hematopoietic stem cell transplantation recipients.
Topics: Adult; Bacteremia; Carbapenems; Hematopoietic Stem Cell Transplantation; Humans; Pseudomonas aeruginosa; Retrospective Studies | 2023 |
Genomic characterization of two carbapenem-resistant
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Genome, Bacterial; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Serratia Infections; Serratia marcescens | 2023 |
Incidence, mortality, and risk factors associated with carbapenem-resistant Acinetobacter baumannii bacteremia within 30 days after liver transplantation.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Humans; Incidence; Liver Transplantation; Risk Factors | 2023 |
Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefepime; Cefoxitin; Citrobacter freundii; Enterobacter aerogenes; Enterobacter cloacae; Humans; Microbial Sensitivity Tests; Morganella morganii; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Serratia marcescens | 2023 |
Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefiderocol; Colistin; COVID-19; Fosfomycin; Humans; Pneumonia, Ventilator-Associated | 2023 |
Prevalence and Outcomes of Carbapenem-resistant Bloodstream Infection in Children With Cancer.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Female; Hematologic Neoplasms; Humans; Klebsiella Infections; Male; Neutropenia; Prevalence; Retrospective Studies; Shock, Septic | 2023 |
Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Ertapenem; Escherichia coli; Humans; Propensity Score; Prospective Studies; Shock, Septic | 2023 |
Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study.
Topics: Bacteremia; Carbapenems; Cohort Studies; COVID-19; Cross Infection; Female; Hospitals; Humans; Intensive Care Units; Male; Prospective Studies; Risk Factors; Sepsis | 2023 |
Blood Stream Infection Caused by Carbapenem-resistant Chryseobacterium indologenes Harboring blaNDM-1 Gene Isolated from a Tertiary Care Hospital in Tripura: An Emerging Threat.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Tertiary Care Centers | 2022 |
Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors | 2023 |
Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae bacteraemia in children: a retrospective study.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Sepsis; Shock, Septic | 2023 |
Colonization by multidrug-resistant bacteria in hematological patients undergoing hematopoietic stem cell transplantation and clinical outcomes: A single-center retrospective cohort study.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Hematopoietic Stem Cell Transplantation; Humans; Klebsiella pneumoniae; Neutropenia; Retrospective Studies; Sepsis | 2023 |
Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales.
Topics: Adult; Aged; Bacteremia; Carbapenems; Cefepime; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis | 2023 |
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Disease Susceptibility; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Sepsis | 2023 |
In host evolution of beta lactam resistance during active treatment for
Topics: Bacteremia; beta-Lactam Resistance; Carbapenems; Humans; Pseudomonas aeruginosa; Sepsis; United States | 2023 |
Clinical impact of COVID-19 in patients with carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; COVID-19; Humans; Retrospective Studies | 2023 |
Cefoxitin versus carbapenems as definitive treatment for extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteremia in intensive care unit: a propensity-matched retrospective analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefoxitin; Escherichia coli; Humans; Klebsiella pneumoniae; Retrospective Studies | 2023 |
Characterization of ESBL-Producing
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Infant; Microbial Sensitivity Tests; Peru; Salmonella; Salmonella enterica; Salmonella Infections; Serogroup | 2019 |
The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers; Tigecycline; Young Adult | 2019 |
Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Europe; European Union; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sentinel Surveillance | 2019 |
Diabetic status and the relationship of blood glucose to mortality in adults with carbapenem-resistant Acinetobacter baumannii complex bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood Glucose; Carbapenems; Diabetes Complications; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Taiwan | 2019 |
Bloodstream infections and carbapenem-resistant Enterobacteriaceae in South Korea.
Topics: Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Developing Countries; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Prospective Studies; Republic of Korea | 2019 |
Colistin, Hot Potato for the Therapy of Carbapenem-resistant
Topics: Acinetobacter baumannii; Bacteremia; Carbapenems; Colistin; Humans; Prognosis; Propensity Score; Solanum tuberosum | 2019 |
[Carbapenem-producing Enterobacteriaceae bloodstream infection: Microbiology's role in their rapid detection].
Topics: Bacteremia; Bacteriological Techniques; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Middle Aged; Time Factors | 2019 |
Mortality risk of bloodstream infection caused by either Escherichia coli or Klebsiella pneumoniae producing extended-spectrum β-lactamase: a prospective cohort study.
Topics: Adolescent; Adult; Aged; Bacteremia; beta-Lactamases; Carbapenems; Child; Child, Preschool; Escherichia coli; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Risk Factors; Survival Rate | 2019 |
Aminoglycoside versus carbapenem or piperacillin/tazobactam treatment for bloodstream infections of urinary source caused by Gram-negative ESBL-producing Enterobacteriaceae.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Urinary Tract Infections | 2020 |
Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cefepime; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2020 |
Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2020 |
Risk factors for acute kidney injury in critically ill patients with bacteraemia by carbapenem non-susceptible Gram negative bacteria.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors | 2019 |
Antimicrobial resistance of bacteraemia in the emergency department of a German university hospital (2013-2018): potential carbapenem-sparing empiric treatment options in light of the new EUCAST recommendations.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Emergency Service, Hospital; Enterobacteriaceae; Germany; Hospitals, University; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus aureus; Tazobactam; Treatment Outcome | 2019 |
Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; China; Cohort Studies; Coinfection; Hospitals, Teaching; Humans; Length of Stay; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Sex Distribution | 2018 |
Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies | 2020 |
Mortality associated with carbapenem-susceptible and Verona Integron-encoded Metallo-β-lactamase-positive Pseudomonas aeruginosa bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Female; Genes, Bacterial; Humans; Integrons; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Tertiary Care Centers | 2020 |
Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Carbapenems; Child; Child, Preschool; China; Female; Hematologic Diseases; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Young Adult | 2019 |
Whole genome sequencing of carbapenem-resistant
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Outbreaks; Evolution, Molecular; Female; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Whole Genome Sequencing; Young Adult | 2020 |
Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Therapy, Combination; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2020 |
Advanced Age is not a Risk Factor for Mortality in Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Organisms: a Multicenter Cohort Study.
Topics: Age Distribution; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cohort Studies; Comorbidity; Female; Humans; Japan; Male; Retrospective Studies; Risk Factors | 2020 |
Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; DNA, Bacterial; Enterobacteriaceae Infections; Epidemiological Monitoring; Female; Humans; Male; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; South Africa; Tertiary Care Centers | 2020 |
A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors | 2020 |
Highly antimicrobial-resistant Nontyphoidal Salmonella from retail meats and clinical impact in children, Taiwan.
Topics: Adolescent; Animals; Anti-Bacterial Agents; Arthritis, Infectious; Bacteremia; Carbapenems; Cattle; Chickens; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Infant; Intestinal Perforation; Male; Meat; Megacolon, Toxic; Microbial Sensitivity Tests; Salmonella; Salmonella Food Poisoning; Swine; Taiwan | 2020 |
The effect of intervention by an antimicrobial stewardship team on anaerobic bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Bacteria, Anaerobic; Carbapenems; Female; Hospitals, University; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prognosis; Treatment Outcome | 2020 |
Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Carbapenems; Controlled Before-After Studies; Female; Humans; Interrupted Time Series Analysis; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Practice Guidelines as Topic; Retrospective Studies; Stem Cell Transplantation; Vancomycin | 2020 |
Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Saudi Arabia; Young Adult | 2020 |
Management of carbapenem-resistant Klebsiella pneumoniae infection in a patient with diabetic foot ulcer and necrotizing soft tissue infection, bacteremia and lung infection: A case report.
Topics: Aged; Amputation, Surgical; Bacteremia; Carbapenems; Debridement; Diabetic Foot; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Leg; Male; Necrosis; Negative-Pressure Wound Therapy; Pneumonia, Bacterial; Soft Tissue Infections | 2020 |
Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; China; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Respiratory Tract Infections; Risk Factors | 2020 |
Colistin monotherapy versus colistin-based combination therapy for treatment of bacteremia in burn patients due to carbapenem-resistant gram negative bacteria.
Topics: Adult; Aged; Bacteremia; Burns; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Republic of Korea; Retrospective Studies | 2020 |
TDM-guided medication of polymyxin B in a patient with CRKP-induced bloodstream infection: a case report.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Diagnosis, Differential; Drug Administration Schedule; Drug Resistance, Bacterial; Fever; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymyxin B | 2021 |
Epidemiology, mortality and risk factors for patients with K. pneumoniae bloodstream infections: Clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Universities | 2020 |
Impact of Incremental Delays in Appropriate Therapy on the Outcomes of Hospitalized Adult Patients with Gram-negative Bloodstream Infections: "Every day matters".
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; New York; Patient Discharge; Retrospective Studies; Time-to-Treatment; Young Adult | 2020 |
IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Porins | 2021 |
Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project).
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Humans; Kidney Transplantation; Lactams; Retrospective Studies; Urinary Tract Infections | 2021 |
Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tazobactam | 2020 |
Clinical impact of cefepime breakpoint in patients with carbapenem-resistant Klebsiella pneumoniae bacteraemia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefepime; Drug Therapy, Combination; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged | 2021 |
Carbapenem-resistant Enterobacterales bacteriuria and subsequent bacteremia: A population-based study.
Topics: Bacteremia; Bacteriuria; Carbapenems; Catheters, Indwelling; Humans; Urinary Catheterization | 2021 |
[Clinical, epidemiological and microbiological characterization of bacteremia produced by carbapenem-resistant enterobacteria in a university hospital in Córdoba, Argentina].
Topics: Anti-Bacterial Agents; Argentina; Bacteremia; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies | 2020 |
External validation of INCREMENT-CPE score in a retrospective cohort of carbapenemase-producing Klebsiella pneumoniae bloodstream infections in critically ill patients.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cohort Studies; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results; Retrospective Studies; Sepsis | 2021 |
Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Organ Failure; Prognosis; Retrospective Studies; Risk Factors; Treatment Outcome | 2021 |
Treatment outcome and adverse effects of colistin in adult patients with carbapenem-resistant gram-negative bacteremia from Pakistan.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pakistan; Prospective Studies; Treatment Outcome | 2021 |
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
Topics: Adult; Aged; Allografts; Anti-Bacterial Agents; Autografts; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Tazobactam; Treatment Outcome; Young Adult | 2021 |
The prediction values of carbapenemase detection methods and carbapenem susceptibility testing for clinical outcomes of patients with Acinetobacter bacteremia under carbapenem treatment.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Retrospective Studies | 2022 |
Carbapenem-resistant Serratia marcescens bloodstream infection in hematopoietic stem cell transplantation patients: Will it be the next challenge?
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Hematopoietic Stem Cell Transplantation; Humans; Serratia marcescens | 2021 |
Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China.
Topics: Bacteremia; Carbapenems; China; Humans; Pseudomonas aeruginosa; Retrospective Studies; Risk Factors; Sepsis; Socioeconomic Factors | 2021 |
First case report of acute cholangitis secondary to Cronobacter sakazakii.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cholangitis; Cholecystostomy; Cronobacter sakazakii; Drainage; Enterobacteriaceae Infections; Humans; Male; Opportunistic Infections; Polymerase Chain Reaction; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Parallel Validation of the NG-Test Carba 5 and the Xpert Carba-R for Detection and Characterization of Carbapenem-Resistant Enterobacterales Causing Bloodstream Infections.
Topics: Adult; Aged; Bacteremia; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Sensitivity and Specificity | 2021 |
Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia.
Topics: Aged; Aged, 80 and over; Bacteremia; Carbapenems; Cost of Illness; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; United States; Urinary Tract Infections | 2021 |
Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial
Topics: Adult; Aged; Bacteremia; Carbapenems; Ertapenem; Female; Hospitalization; Humans; Imipenem; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2021 |
Risk factors and clinical impact of bacteremia due to carbapenem-nonsusceptible Enterobacteriaceae: A multicenter study in southern Taiwan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Odds Ratio; Risk Factors; Taiwan | 2021 |
Clinical characteristics and risk factors associated with secondary bloodstream infection in patients with intensive care unit-acquired pneumonia due to carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia; Risk Factors | 2021 |
Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Propensity Score; Treatment Outcome | 2017 |
EUropean prospective cohort study on
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cause of Death; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Hospitalization; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Mortality; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome; Urinary Tract Infections | 2017 |
Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Fluoroquinolones; Hematologic Neoplasms; Hospitalization; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Treatment Outcome | 2017 |
Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2017 |
Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cohort Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Neutropenia | 2017 |
Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Blood Culture; Carbapenems; Child; Child, Preschool; China; Drug Resistance, Multiple, Bacterial; Female; Gene Expression Regulation, Bacterial; Hospitals, Pediatric; Humans; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Survival Analysis | 2018 |
Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections.
Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; beta-Lactams; Blood Culture; Carbapenems; Gram-Negative Bacteria; Humans; Prospective Studies | 2017 |
Importance of Carbapenemase Production Detection in Carbapenem-Resistant Enterobacteriaceae: Looking Beyond Epidemiological Purposes.
Topics: Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans | 2017 |
Lipid peroxidation in Gram-negative bacteremia modulates the risk for septic shock and infections by resistant Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Antioxidants; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipid Peroxidation; Male; Malondialdehyde; Neutrophils; Prospective Studies; Risk Factors; Shock, Septic | 2017 |
Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Inappropriate Prescribing; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies | 2017 |
Transdermally administered proline-arginine-rich host defense peptides show systemic efficacy in a lethal mouse bacteremia model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Cutaneous; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Arginine; Bacteremia; Bacterial Load; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Ear; Humans; Mice; Proline; Skin; Survival Analysis | 2017 |
Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Comorbidity; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2017 |
Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Disease Susceptibility; Drug Resistance, Bacterial; Female; Humans; Immunocompromised Host; Male; Middle Aged; Minocycline; Risk Factors; Tigecycline | 2017 |
Should we treat patients with only one set of positive blood cultures for extensively drug-resistant Acinetobacter baumannii the same as multiple sets?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Leukopenia; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Severity of Illness Index; Survival Analysis; Thrombocytopenia | 2017 |
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Topics: Adolescent; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fever; Fluoroquinolones; Humans; Male; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins | 2017 |
Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Humans; Japan; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2017 |
Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A single-center retrospective study of 75 cases in India.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2017 |
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
Topics: Aged; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Propensity Score; Tertiary Care Centers; Tigecycline; Treatment Outcome | 2018 |
Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Germany; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Care Centers | 2018 |
The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacteremia; Carbapenems; Cohort Studies; Colistin; Critical Illness; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Propensity Score; Survival Analysis; Tigecycline; Treatment Outcome | 2018 |
Case report of transient mcr-1-haboring Escherichia coli with concurrent Staphylococcus aureus bacteremia in Long Beach, California.
Topics: Bacteremia; California; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Plasmids; Staphylococcal Infections; Staphylococcus aureus | 2017 |
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies | 2017 |
Impact of Penicillin Allergy on Time to First Dose of Antimicrobial Therapy and Clinical Outcomes.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Hypersensitivity; Emergency Service, Hospital; Female; Hospitalization; Humans; Male; Middle Aged; Patient Readmission; Penicillins; Pneumonia; Retrospective Studies; Sepsis; Urinary Tract Infections | 2017 |
Clinical outcomes of elderly patients with bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae in an Italian Internal Medicine ward.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Italy; Male; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Treatment Outcome | 2018 |
High mortality of bloodstream infection outbreak caused by carbapenem-resistant P. aeruginosa producing SPM-1 in a bone marrow transplant unit.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Adhesion; Bacterial Proteins; beta-Lactamases; Biofilms; Bone Marrow Transplantation; Brazil; Carbapenems; Case-Control Studies; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Genome-Wide Association Study; Humans; Length of Stay; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2017 |
Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Carbapenems; Cohort Studies; Drug Hypersensitivity; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Penicillins; Practice Patterns, Physicians'; Retrospective Studies; Time Factors | 2018 |
Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil?
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Microbial Sensitivity Tests; Plasmids | 2017 |
Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Citrobacter freundii; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxin B; Urinary Tract Infections | 2018 |
Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2018 |
β LACTA testing may not improve treatment decisions made with MALDI-TOF MS-informed antimicrobial stewardship advice for patients with Gram-negative bacteraemia: a prospective comparative study.
Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; beta-Lactamases; Carbapenems; Clinical Decision-Making; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
High excess costs of infections caused by carbapenem-resistant Gram-negative bacilli in an endemic region.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colombia; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Female; Gram-Negative Bacterial Infections; Health Care Costs; Humans; Intraabdominal Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Surgical Wound Infection | 2018 |
Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Female; Genes, Bacterial; Genome, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2018 |
Extensively drug-resistant Acinetobacter baumannii bacteraemia in a multidisciplinary intensive care unit during a 6-year period: Risk factors for fulminant sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies; Risk Factors; Sepsis | 2018 |
Emergence of Carbapenem Non-susceptible Campylobacter coli after Long-term Treatment against Recurrent Bacteremia in a Patient with X-linked Agammaglobulinemia.
Topics: Adult; Agammaglobulinemia; Anti-Bacterial Agents; Bacteremia; Campylobacter coli; Campylobacter Infections; Carbapenems; Drug Resistance, Bacterial; Genetic Diseases, X-Linked; Humans; Infusions, Intravenous; Long-Term Care; Male | 2018 |
Research and analysis of 74 bloodstream infection cases of Acinetobacter baumannii and drug resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2018 |
Emergence of carbapenem-resistant Acinetobacter nosocomialis strain ST410 harbouring plasmid-borne bla
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Plasmids; Retrospective Studies; Taiwan | 2018 |
Carbapenem-resistant Acinetobacter baumannii Bacteremia in Liver Transplant Recipients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Female; Humans; Incidence; Liver Transplantation; Living Donors; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Postoperative Complications; Risk Factors | 2018 |
Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Febrile Neutropenia; Humans; Invasive Pulmonary Aspergillosis; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2018 |
Rapid detection of carbapenemase activity of Enterobacteriaceae isolated from positive blood cultures by MALDI-TOF MS.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Child; Child Mortality; Child, Preschool; China; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis | 2018 |
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Databases, Factual; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prognosis; Retrospective Studies; Treatment Outcome; United States; Young Adult | 2018 |
A prognostic score for the resolution of bacteremia by Gram-negative bacteria resistant to carbapenems.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Biomarkers; Carbapenems; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Prognosis | 2018 |
Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Chryseobacterium; Drug Resistance, Bacterial; Female; Flavobacteriaceae Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Pseudomonas aeruginosa; Retrospective Studies; Stenotrophomonas maltophilia; Taiwan; Tertiary Care Centers | 2019 |
Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Case-Control Studies; Cefoperazone; China; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam | 2018 |
The epidemiological impact and significance of carbapenem resistance in Pseudomonas aeruginosa bloodstream infections: a matched case-case-control analysis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Female; Hospital Mortality; Humans; Israel; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Survival Analysis | 2018 |
No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Female; Genes, Bacterial; Humans; Klebsiella pneumoniae; Male; Mutation; Phylogeny; Virulence; Virulence Factors | 2018 |
Carbapenem-Sparing Therapy for Extended-Spectrum β-Lactamase-Producing E coli and Klebsiella pneumoniae Bloodstream Infection: The Search Continues.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Extended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Cephalosporins; China; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Male; Middle Aged; Rectal Diseases; Retrospective Studies; Risk Factors | 2018 |
Increased Relative Abundance of Klebsiella pneumoniae Carbapenemase-producing Klebsiella pneumoniae Within the Gut Microbiota Is Associated With Risk of Bloodstream Infection in Long-term Acute Care Hospital Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Female; Gastrointestinal Microbiome; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; ROC Curve | 2019 |
Implementation of an empirical antimicrobial protocol in a critical care setting: A single-center retrospective observational cohort study in bacteremic patients.
Topics: Aged, 80 and over; Anti-Infective Agents; Antimicrobial Stewardship; Bacteremia; Carbapenems; Cohort Studies; Community-Acquired Infections; Critical Care; Cross Infection; Female; Humans; Male; Retrospective Studies; Treatment Outcome | 2018 |
Transmission of IMI-2 carbapenemase-producing Enterobacteriaceae from river water to human.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Male; Plasmids; Rivers | 2018 |
Risk factors for mortality among carbapenem-resistant enterobacteriaceae carriers with focus on immunosuppression.
Topics: Aged; Aged, 80 and over; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Case-Control Studies; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Immunosuppression Therapy; Israel; Male; Middle Aged; Prospective Studies; Risk Factors | 2019 |
Carbapenem-resistant Gram-negative bloodstream infections in critically ill children: outcome and risk factors in a tertiary teaching hospital in South America.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Critical Illness; Female; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Infant; Male; Risk Factors; South America; Survival Analysis; Tertiary Care Centers; Treatment Outcome | 2019 |
Changes in the early mortality of adult patients with carbapenem-resistant Acinetobacter baumannii bacteremia during 11 years at an academic medical center.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Catheter-Related Infections; Cross Infection; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Risk Factors | 2019 |
Does Quick Sepsis-Related Organ Failure Assessment Suggest the Use of Initial Empirical Carbapenem Therapy in Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Bacteria? :A Multicenter Case-Control Study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals; Humans; Male; Middle Aged; Organ Dysfunction Scores; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2019 |
Clonal relationship and the association of the ST218 strain harboring bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Multivariate Analysis; Risk Factors; Taiwan; Virulence; Virulence Factors | 2019 |
The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Critical Illness; Drug Resistance, Bacterial; Female; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Rectum; Risk Factors; Young Adult | 2019 |
Using local clinical and microbiological data to develop an institution specific carbapenem-sparing strategy in sepsis: a nested case-control study.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cephalosporins; Cohort Studies; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 2019 |
Phenotypic and molecular detection methods for carbapenemase-producing organisms and their clinical significance at two Scottish tertiary care hospitals.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Hydrolysis; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Phenotype; Real-Time Polymerase Chain Reaction; Scotland; Sensitivity and Specificity; Tertiary Care Centers | 2019 |
Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Catheter-Related Infections; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Male; Middle Aged; Mortality; Pneumonia; Retrospective Studies; Risk Factors | 2019 |
Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Animals; Anti-Bacterial Agents; Bacteremia; Carbapenems; Community-Acquired Infections; Disease Models, Animal; Female; Hospitals; Humans; Kaplan-Meier Estimate; Larva; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Retrospective Studies; Risk Factors; Virulence | 2019 |
Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Febrile Neutropenia; Feces; Female; Gram-Positive Bacterial Infections; Humans; Leukemia; Male; Middle Aged; Multilocus Sequence Typing; Regression Analysis; Retrospective Studies; Vancomycin-Resistant Enterococci; Young Adult | 2019 |
Carbapenem-resistant Enterobacteriaceae: global action required.
Topics: Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Developing Countries; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Prospective Studies | 2019 |
Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Developing Countries; Enterobacteriaceae Infections; Female; Hematologic Diseases; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies | 2019 |
Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
Topics: Acinetobacter baumannii; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Oman; Prevalence; Pseudomonas aeruginosa | 2019 |
Derivation and validation of a simple score to predict the presence of bacteria requiring carbapenem treatment in ICU-acquired bloodstream infection and pneumonia: CarbaSCORE.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; France; Hospitals, University; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Predictive Value of Tests; Prospective Studies; Retrospective Studies; Severity of Illness Index; Young Adult | 2019 |
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Bacteremia; beta-Lactam Resistance; Carbapenems; Comorbidity; Cross Infection; Disease Management; Drug Resistance, Multiple, Bacterial; Female; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Patient Outcome Assessment; Proportional Hazards Models; Prospective Studies; Tertiary Care Centers | 2019 |
Emergence of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Hong Kong; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Retrospective Studies | 2019 |
The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic Infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prospective Studies; Retrospective Studies; Risk Factors | 2020 |
Risk factors for carbapenem resistance and outcomes when treating bloodstream infections in a paediatric intensive care unit.
Topics: Adolescent; Bacteremia; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Retrospective Studies | 2019 |
Carbapenem sparing in the management of post-transrectal prostate biopsy bacteraemia.
Topics: Aged; Aged, 80 and over; Bacteremia; Carbapenems; Humans; Image-Guided Biopsy; Male; Middle Aged; Postoperative Complications; Prostate; Prostatic Neoplasms; Rectum; Retrospective Studies; Ultrasonography, Interventional | 2019 |
Extremely High Mortality Rates in Patients with Carbapenem-resistant, Hypermucoviscous Klebsiella pneumoniae Blood Stream Infections.
Topics: Bacteremia; Carbapenems; Drug Resistance, Bacterial; Humans; India; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
Bloodstream infections caused by Entero-bacteriaceae in China.
Topics: Bacteremia; Carbapenems; China; Developing Countries; Enterobacteriaceae; Humans; Prospective Studies | 2019 |
The need for adequate research data on carbapenem use and resistance in Bangladesh.
Topics: Bacteremia; Bangladesh; beta-Lactamases; Carbapenems; Developing Countries; Enterobacteriaceae; Humans; Prospective Studies | 2019 |
Validation of a carbapenem-resistant Enterobacteriaceae colonization risk prediction model: A retrospective cohort study in Korean intensive care units.
Topics: Age Factors; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Middle Aged; Prognosis; Republic of Korea; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Sex Factors | 2019 |
Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome; Urinary Tract Infections | 2013 |
Persistence of Klebsiella pneumoniae clones with OXA-48 or NDM carbapenemases causing bacteraemias in a Riyadh hospital.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Saudi Arabia | 2013 |
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Treatment Outcome | 2013 |
Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010).
Topics: Bacteremia; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Promoter Regions, Genetic; Sequence Analysis, DNA; United States | 2013 |
Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients.
Topics: Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Greece; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors | 2013 |
Empirical antimicrobial therapy for critically ill patients with Acinetobacter baumannii bacteremia: combination is better.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteremia; beta-Lactam Resistance; Carbapenems; Female; Humans; Male | 2013 |
Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; beta-Lactamases; Brazil; Carbapenems; Cystic Fibrosis; Demography; Drug Resistance, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Phenotype; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum | 2013 |
The clinical characteristics, carbapenem resistance, and outcome of Acinetobacter bacteremia according to genospecies.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Female; Genotype; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Risk Factors; Treatment Outcome | 2014 |
Verona integron-encoded metallo-β-lactamase 1 in Enterobacteria, Ontario, Canada.
Topics: Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; Bacteriuria; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Female; Humans; Integrons; Male; Middle Aged; Multilocus Sequence Typing | 2013 |
Reply to Altshuler et al.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2013 |
Treatment of extended-spectrum Beta-lactamase enterobacteriaceae with cefepime: the dose matters, too.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2013 |
Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Female; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Statistics, Nonparametric | 2013 |
Clostridium perfringens sepsis following a molar pregnancy.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Clostridium Infections; Clostridium perfringens; Dilatation and Curettage; Female; Humans; Hydatidiform Mole; Hysterectomy; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Suction | 2014 |
[Analysis of resistance tendency of bloodstream-infecting pathogens in China].
Topics: Acinetobacter baumannii; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests | 2013 |
Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacteria; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Neoplasms | 2014 |
Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2013 |
Enterobacteriaceae bacteremia: risk factors for ESBLPE.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Child; Child, Preschool; Databases, Factual; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Departments; Hospitals, Teaching; Humans; Infant; Infant, Newborn; Male; Middle Aged; Paris; Prevalence; Prospective Studies; Risk Factors; Substrate Specificity; Young Adult | 2014 |
A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Central Venous Catheters; Cephalosporins; Coinfection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome | 2014 |
Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU.
Topics: Bacteremia; Carbapenems; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Retrospective Studies; Risk Factors; Treatment Outcome | 2014 |
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Adult; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Fatal Outcome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Treatment Outcome | 2014 |
Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Sulbactam; Treatment Outcome | 2014 |
Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome | 2014 |
Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; DNA, Bacterial; DNA, Intergenic; DNA, Ribosomal; Fluoroquinolones; Humans; Microbial Sensitivity Tests; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2015 |
Bloodstream infection with carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Acinetobacter baumannii: a case report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Shock, Septic | 2014 |
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin | 2013 |
A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Female; Genotype; Humans; Israel; Male; Middle Aged; Molecular Typing; Risk Factors; Sequence Analysis, DNA; Survival Analysis | 2014 |
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prospective Studies; Retrospective Studies | 2014 |
Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Colistin; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Hospital Mortality; Humans; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2014 |
Case-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cephalosporins; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2014 |
Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Biofilms; Carbapenems; Cohort Studies; Female; Hospitals, Teaching; Humans; Male; Middle Aged; Pancreatic Elastase; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Outcome; Virulence; Virulence Factors | 2014 |
Risk factors for carbapenem-resistant Acinetobacter baumanii blood stream infections in a neonatal intensive care unit, Delhi, India.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteremia; beta-Lactam Resistance; Carbapenems; Cross Infection; Female; Humans; India; Infant, Newborn; Intensive Care, Neonatal; Male; Risk Factors; Survival Analysis | 2014 |
Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2014 |
Risk factors for carbapenem resistant bacteraemia and mortality due to gram negative bacteraemia in a developing country.
Topics: Adult; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Male; Middle Aged; Multivariate Analysis; Pakistan; Prospective Studies; Risk Factors | 2014 |
Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Respiration, Artificial; Retrospective Studies; Risk Factors; Severity of Illness Index | 2014 |
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Critical Illness; Cross Infection; Decision Support Techniques; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Risk Factors; Surgical Procedures, Operative; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 2014 |
Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2015 |
High prevalence of carbapenem resistance among plasmid-mediated AmpC β-lactamase-producing Klebsiella pneumoniae during outbreaks in liver transplantation units.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Disease Outbreaks; DNA, Bacterial; Female; Hospitals, University; Humans; Infection Control; Japan; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Young Adult | 2015 |
Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from blood by heparin-functional hemoperfusion media.
Topics: Adsorption; Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Adhesion; beta-Lactam Resistance; Carbapenems; Escherichia coli; Hemoperfusion; Heparin; Horses; Humans; Klebsiella pneumoniae | 2014 |
Clinical outcomes of children with carbapenem-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Prognosis; Retrospective Studies; Thailand; Treatment Outcome | 2014 |
Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Therapy, Combination; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Retrospective Studies | 2015 |
Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; APACHE; Bacteremia; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Minocycline; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Tigecycline | 2016 |
Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cohort Studies; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Proportional Hazards Models; Proteus mirabilis; Survival Rate; Time Factors | 2015 |
Editorial commentary: Bloodstream infection caused by extended-spectrum β-lactamase-producing Gram-negative bacteria: how to define the best treatment regimen?
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Enterobacteriaceae Infections; Female; Humans; Male; Penicillanic Acid | 2015 |
Molecular epidemiological survey of the quinolone- and carbapenem-resistant genotype and its association with the type III secretion system in Pseudomonas aeruginosa.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Secretion Systems; Brazil; Carbapenems; Child; Child, Preschool; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Genotype; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Virulence Factors; Young Adult | 2015 |
Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Bacteremia; Carbapenems; Carrier State; Diarrhea; Febrile Neutropenia; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Typing; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Vancomycin-Resistant Enterococci; Young Adult | 2015 |
Evaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, national healthcare safety network, 2011.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Carbapenems; Catheter-Related Infections; Child; Child, Preschool; Disease Notification; Drug Resistance, Bacterial; Female; Humans; Incidence; Infant; Intensive Care Units; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Public Health Surveillance; Risk Adjustment; Staphylococcal Infections; United States; Young Adult | 2015 |
Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors.
Topics: Aged; Aged, 80 and over; Bacteremia; Carbapenems; Carrier State; Case-Control Studies; Drug Resistance, Bacterial; Female; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies | 2015 |
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Incidence; Italy; Population Surveillance; Seasons | 2015 |
Fulminant endocarditis and disseminated infection caused by carbapenem-resistant Acinetobacter baumannii in a renal-pancreas transplant recipient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Diabetes Mellitus, Type 1; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Postoperative Complications | 2015 |
Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Italy; Male; Middle Aged; Organ Transplantation; Risk Factors; Transplant Recipients | 2015 |
Impact of combination antimicrobial therapy on mortality risk for critically ill patients with carbapenem-resistant bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Critical Illness; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Rate; Systemic Inflammatory Response Syndrome | 2015 |
Monitoring antibiotic-resistant enterobacteria faecal levels is helpful in predicting antibiotic susceptibility of bacteraemia isolates in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Young Adult | 2015 |
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Intraabdominal Infections; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections | 2015 |
[Evaluation of Antibiotics for the Treatment of Bacteremia Due to Extended-spectrum β-Lactamase-producing Escherichia coli].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefmetazole; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk; Treatment Outcome; Young Adult | 2015 |
Determining the resistance of carbapenem-resistant Klebsiella pneumoniae to common disinfectants and elucidating the underlying resistance mechanisms.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Disinfectants; Drug Resistance, Bacterial; Hospitals; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Treatment Outcome | 2015 |
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins | 2017 |
Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis | 2015 |
OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Genotype; Hospitals, University; Humans; Inpatients; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Multiplex Polymerase Chain Reaction; Tigecycline; Turkey | 2015 |
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Sulbactam; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2016 |
Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.
Topics: Anti-Bacterial Agents; Antiviral Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Colectomy; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Thienamycins; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; Valganciclovir | 2015 |
Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospectiv
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2015 |
Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2015 |
Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2017 |
Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy.
Topics: Aged; Aged, 80 and over; Bacteremia; Carbapenems; Female; Hospitals, Teaching; Humans; Intensive Care Units; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies | 2015 |
First report of New Delhi metallo-β-lactamase 5 (NDM-5)-producing Escherichia coli from blood cultures of three leukemia patients.
Topics: Adult; Bacteremia; beta-Lactamases; Carbapenems; China; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Humans; Leukemia; Male; Middle Aged | 2016 |
Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Drug Administration Schedule; Drug Dosage Calculations; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2016 |
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Ertapenem; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Survival Analysis; Treatment Outcome; Urinary Tract Infections | 2016 |
First identification of an IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae in China.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Colistin; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Leukemia; Male; Molecular Sequence Data; Molecular Typing; Sequence Analysis, DNA | 2015 |
Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. Bacteremia.
Topics: Aged; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Length of Stay; Male; Middle Aged; Risk Factors; Severity of Illness Index; Treatment Outcome | 2015 |
[Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; China; Cross Infection; Hospitals, Teaching; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline; Vancomycin | 2015 |
Association of Risk Factors, Antimicrobial Resistance Trends and Occurrence of blaTEM, bla SHV and blaCTX M in Escherichia coli Causing Bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Diabetes Complications; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Phenotype; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Urinary Tract Infections | 2016 |
Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Multidrug Resistance-Associated Proteins; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea; Thienamycins | 2016 |
Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Colistin; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Humans; India; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Tertiary Care Centers; Treatment Outcome; Young Adult | 2015 |
First the ESBLs, now the Carbapenemases: Where will it End?
Topics: Bacteremia; beta-Lactam Resistance; Carbapenems; Female; Gram-Negative Bacterial Infections; Humans; Male | 2015 |
Characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex isolates from nosocomial bloodstream infections in southern Iran.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genetic Variation; Genotype; Humans; Iran | 2016 |
Bundled strategies against infection after liver transplantation: Lessons from multidrug-resistant Pseudomonas aeruginosa.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Calcitonin; Carbapenems; Clinical Protocols; Drug Resistance, Multiple, Bacterial; Female; Hand Hygiene; Humans; Incidence; Infection Control; Japan; Length of Stay; Liver Diseases; Liver Transplantation; Living Donors; Male; Middle Aged; Pseudomonas aeruginosa; Treatment Outcome; Young Adult | 2016 |
[Clinical features and antibiotic resistance of Escherichia coli bloodstream infections in children].
Topics: Adolescent; Bacteremia; beta-Lactamases; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Pneumonia; Urinary Tract Infections | 2016 |
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney Transplantation; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Surgical Wound Infection; Thienamycins | 2016 |
Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged | 2016 |
Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Carbapenems; Ciprofloxacin; Cohort Studies; Febrile Neutropenia; Female; Humans; Leukemia; Male; Middle Aged; Mycoses | 2016 |
Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae; Female; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2016 |
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies | 2016 |
A rare cause of infection, Raoultella planticola: emerging threat and new reservoir for carbapenem resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Middle Aged; Retrospective Studies; Risk Factors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Young Adult | 2016 |
Antimicrobial Susceptibility among European Gram-Negative and Gram-Positive Isolates Collected as Part of the Tigecycline Evaluation and Surveillance Trial (2004-2014).
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Minocycline; Pseudomonas aeruginosa; Thienamycins; Tigecycline | 2017 |
Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994-2012.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Burn Units; Burns; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella; Klebsiella Infections; Linear Models; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Sweden; Urinary Tract Infections; Wound Infection; Young Adult | 2016 |
[The clinical characteristics analysis of Escherichia coli bloodstream infection].
Topics: Bacteremia; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors | 2016 |
Rapid Blue-Carba test: reduction in the detection time of carbapenemases performed from a 4-hour bacterial lawn.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Argentina; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Inactivation, Metabolic; Molecular Typing; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Time Factors | 2017 |
Bacteremia Due to Arthrobacter creatinolyticus in an Elderly Diabetic Man with Acute Cholangitis.
Topics: Aerobiosis; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Arthrobacter; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cholangitis; Diabetes Complications; DNA, Bacterial; DNA, Ribosomal; Doripenem; Gram-Positive Bacterial Infections; Humans; Male; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sulbactam | 2017 |
Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; New York City; Prevalence; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2016 |
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.
Topics: Antibiotic Prophylaxis; Bacteremia; Carbapenems; Cohort Studies; Drug Resistance, Microbial; Female; Hematologic Neoplasms; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Registries | 2016 |
Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008-2014.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacteria; Blood Culture; Carbapenems; Drug Resistance, Bacterial; Female; Humans; India; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Young Adult | 2016 |
[Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacteriuria; beta-Lactamases; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sulbactam; Trachea; Wound Infection | 2016 |
Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefmetazole; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Female; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Urinary Tract Infections | 2016 |
Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Hospitalized; Child, Preschool; Colombia; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Infant; Male; Molecular Epidemiology; Multilocus Sequence Typing; Tertiary Care Centers | 2016 |
Risk factors for hospital-acquired bacteremia due to carbapenem-resistant Pseudomonas aeruginosa in a Colombian hospital.
Topics: Bacteremia; beta-Lactams; Carbapenems; Case-Control Studies; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Hospitals; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Thienamycins | 2016 |
Carbapenem Breakpoints for Acinetobacter baumannii Group: Supporting Clinical Outcome Data from Patients with Bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Bacteremia; Carbapenems; Female; Humans; Middle Aged; Retrospective Studies; Treatment Outcome | 2016 |
Proposed breakpoint of piperacillin/tazobactam against extended spectrum β-lactamases producing bacteria in bacteremia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae; Female; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam | 2017 |
Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Young Adult | 2017 |
Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
Topics: Anaerobiosis; Anti-Infective Agents; Bacteremia; Bacteria, Anaerobic; Bacteroides; Carbapenems; Clindamycin; Clostridium; Drug Resistance, Microbial; Fusobacterium; Gram-Positive Bacteria; Humans; Intraabdominal Infections; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propionibacterium; Retrospective Studies | 2017 |
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2017 |
Use of organs from donors with bloodstream infection, pneumonia, and influenza: Results of a survey of infectious diseases practitioners.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Candidemia; Carbapenems; Clinical Decision-Making; Cross Infection; Donor Selection; Drug Resistance, Bacterial; Humans; Influenza, Human; Pneumonia; Practice Guidelines as Topic; Surveys and Questionnaires; Tissue Donors; Transplants | 2017 |
Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India.
Topics: Adolescent; Bacteremia; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; India; Infant; Infant, Newborn; Male; Retrospective Studies; Risk Factors | 2017 |
Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cohort Studies; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Meropenem; Middle Aged; Retrospective Studies; Thienamycins; Treatment Outcome | 2017 |
Treatment Outcomes in Infections Caused by "SPICE" (Serratia, Pseudomonas, Indole-positive Proteus, Citrobacter, and Enterobacter) Organisms: Carbapenem versus Noncarbapenem Regimens.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Citrobacter; Enterobacter; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Proteus; Pseudomonas; Retrospective Studies; Serratia | 2017 |
Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2017 |
Survival of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 258 in Human Blood.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Carbapenems; Disease Models, Animal; Humans; Klebsiella pneumoniae; Mice; Mice, Inbred BALB C; Multilocus Sequence Typing; Virulence | 2017 |
Colistin- and carbapenem-resistant Klebsiella oxytoca harboring bla
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Blood; Blood Culture; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella oxytoca; Membrane Proteins; Mutagenesis, Insertional; Plasmids | 2017 |
Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Catheter-Related Infections; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Prospective Studies; Salvage Therapy; Thienamycins; Treatment Outcome; Urinary Tract Infections; Young Adult | 2017 |
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Hematologic Neoplasms; Hospitals, Teaching; Humans; Infection Control; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Fever; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Neutropenia; Pakistan; Vancomycin Resistance | 2008 |
Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Predictive Value of Tests | 2008 |
Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Brazil; Carbapenems; Cephalosporins; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Stenotrophomonas maltophilia | 2008 |
Fulminant septicemia of Bacillus cereus resistant to carbapenem in a patient with biphenotypic acute leukemia.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacillus cereus; Bacteremia; beta-Lactam Resistance; Brain Stem; Carbapenems; Fever; Gram-Positive Bacterial Infections; Humans; Leukemia, Biphenotypic, Acute; Liver; Lung; Male; Microbial Sensitivity Tests; Neutropenia; Remission Induction | 2008 |
Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC beta-lactamase in Brazil.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2008 |
Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Middle Aged; Missouri; Predictive Value of Tests | 2009 |
Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Quinolones; Salmonella; Salmonella Infections; Tigecycline; Typhoid Fever | 2009 |
Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Young Adult | 2009 |
A role for carbapenem in the treatment of melioidosis in developing countries?
Topics: Anti-Bacterial Agents; Bacteremia; Burkholderia pseudomallei; Carbapenems; Debridement; Developing Countries; Humans; Leg; Male; Melioidosis; Meropenem; Middle Aged; Thailand; Thienamycins; Treatment Outcome | 2009 |
Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Female; Genotype; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; New York City; Polymyxin B; Ribotyping; Sequence Analysis, DNA | 2009 |
ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Carbapenems; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial | 2009 |
Prolonged bacteraemia caused by VIM-1 metallo-beta-lactamase-producing Proteus mirabilis: first report from Italy.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Chromosomes, Bacterial; DNA, Bacterial; Humans; Integrons; Italy; Male; Meropenem; Plasmids; Proteus Infections; Proteus mirabilis; Surgical Wound Infection; Thienamycins; Treatment Failure; Treatment Outcome | 2010 |
Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Critical Illness; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies | 2009 |
Failure of the MicroScan WalkAway system to detect heteroresistance to carbapenems in a patient with Enterobacter aerogenes bacteremia.
Topics: Anti-Bacterial Agents; Automation; Bacteremia; beta-Lactam Resistance; Carbapenems; Enterobacter aerogenes; Enterobacteriaceae Infections; False Negative Reactions; Humans; Microbial Sensitivity Tests | 2009 |
Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Hospital Mortality; Hospitals, Teaching; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Matched-Pair Analysis; Microbial Sensitivity Tests; Middle Aged | 2009 |
Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Female; Health Policy; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Spain; Treatment Outcome; Young Adult | 2010 |
Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; Cross Infection; Drug Resistance, Bacterial; Female; Greece; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Regression Analysis; Risk Factors | 2010 |
Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Cohort Studies; Female; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Shock, Septic; Treatment Outcome | 2010 |
Bacteremia due to extended-spectrum-beta-lactamase-producing Enterobacter cloacae: role of carbapenem therapy.
Topics: Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Carbapenems; Enterobacter cloacae; Humans; Middle Aged; Retrospective Studies | 2010 |
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
Topics: Anti-Bacterial Agents; Bacteremia; Bile Duct Diseases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2010 |
A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheterization, Central Venous; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Taiwan; Treatment Outcome; Young Adult | 2010 |
Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; Blood; Carbapenems; Cross Infection; Culture Media; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged | 2010 |
Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactamases; Blood; Carbapenems; Culture Media; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gastrointestinal Tract; Humans; India; Intensive Care, Neonatal; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2010 |
Leuconostoc bacteremia in three patients with malignancies.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Female; Gram-Positive Bacterial Infections; Humans; Leuconostoc; Male; Middle Aged; Neoplasms | 2011 |
Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Ciprofloxacin; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Young Adult | 2010 |
Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Korea; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Thienamycins; Urinary Tract Infections | 2011 |
Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Metalloproteins; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Risk Factors; Treatment Outcome; Young Adult | 2010 |
SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Female; Gastrointestinal Tract; Gentamicins; Hematologic Diseases; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pilot Projects; Stem Cell Transplantation | 2011 |
Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Animals; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Models, Animal; Female; Genes, Bacterial; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Republic of Korea; Rifampin; Risk Factors | 2011 |
Should polymyxin be used empirically to treat infections in patients under high risk for carbapenem-resistant Acinetobacter?
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Brazil; Carbapenems; Child; Cross Infection; Female; Humans; Male; Middle Aged; Polymyxins; Survival Analysis; Young Adult | 2011 |
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Prognosis; Retrospective Studies; Tigecycline; Treatment Outcome | 2011 |
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome | 2011 |
Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: a matched case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Liver Diseases; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Regression Analysis; Risk Factors; Survival Analysis; Taiwan; Treatment Outcome; Uremia | 2011 |
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey | 2011 |
Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Incidence; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Thailand; Treatment Outcome; Young Adult | 2011 |
Bloodstream infections with OXA-23-producing Acinetobacter baumannii isolates in a university-affiliated hospital in Brazil: epidemiology and clinical outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Female; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2011 |
Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxins; Retrospective Studies; Treatment Outcome | 2011 |
Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Genotype; Hospitals; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Species Specificity; Thienamycins | 2012 |
Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; Carbapenems; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Real-Time Polymerase Chain Reaction; Republic of Korea | 2012 |
Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Propensity Score; Thienamycins | 2012 |
Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Taiwan; Young Adult | 2012 |
Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Young Adult | 2012 |
Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Regression Analysis; Risk Factors; Spain; Survival Analysis; Treatment Outcome | 2012 |
Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteremia; beta-Lactam Resistance; Carbapenems; Fatal Outcome; Female; Humans; Lung Transplantation; Middle Aged; Time Factors; Tissue Donors | 2012 |
Organ transplantation from a donor colonized with a multidrug-resistant organism: a case report.
Topics: Adolescent; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Lung Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Tissue and Organ Harvesting; Tissue Donors; Young Adult | 2012 |
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
Topics: Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quality Control; Thienamycins | 2012 |
Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: clinical impacts of lowered breakpoints for carbapenems.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Polyacrylamide Gel; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Taiwan | 2012 |
Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.
Topics: Amino Acid Sequence; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression Regulation, Bacterial; Hydrolysis; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutation; Porins; Protein Conformation; Pseudomonas aeruginosa; Pseudomonas Infections; Real-Time Polymerase Chain Reaction; Spain | 2012 |
Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Female; Humans; Immunosuppressive Agents; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Survival Rate; Young Adult | 2012 |
Beta-lactam resistance mechanisms in Pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Species Specificity; United States | 2012 |
High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Cluster Analysis; DNA Transposable Elements; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Genotype; Humans; Microbial Sensitivity Tests; Molecular Typing; Molecular Weight; Polymerase Chain Reaction; Prevalence | 2012 |
Bacteremia caused by Acinetobacter junii at a medical center in Taiwan, 2000-2010.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; Central Venous Catheters; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Taiwan; Tertiary Care Centers; Tigecycline | 2012 |
Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; Carbapenems; Cohort Studies; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Analysis; Taiwan; Treatment Outcome | 2012 |
Persistent carbapenem-resistant Klebsiella pneumoniae bacteremia in a patient with acute lymphoblastic leukemia.
Topics: Bacteremia; beta-Lactam Resistance; Carbapenems; Catheter-Related Infections; Catheterization, Central Venous; Drug Resistance, Multiple; Fatal Outcome; Female; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2012 |
Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification.
Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Probability; Pseudomonas aeruginosa; Retrospective Studies; Survival Rate; Treatment Outcome | 2012 |
Risk factors for carbapenem non-susceptibility and mortality in Acinetobacter baumannii bacteremia in children.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Bacteremia; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; In Vitro Techniques; Infant; Infant, Newborn; Logistic Models; Microbial Sensitivity Tests; Retrospective Studies; Survival Rate; Thailand | 2012 |
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Genotype; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Young Adult | 2013 |
Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Analysis of Variance; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Chi-Square Distribution; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Odds Ratio; Risk Factors; Statistics, Nonparametric; Thailand; Treatment Outcome | 2013 |
The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients.
Topics: Bacteremia; beta-Lactam Resistance; Carbapenems; Cohort Studies; Decision Support Techniques; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Predictive Value of Tests | 2013 |
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2012 |
Bloodstream infections caused by IMP-8-producing Enterobacteriaceae isolates: the need for clinical laboratory detection of metallo-β-lactamases?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Taiwan | 2013 |
Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome | 2013 |
Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests | 2013 |
Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Taiwan; Thienamycins | 2012 |
Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.
Topics: Academic Medical Centers; Adult; Bacteremia; Carbapenems; Ceftazidime; Drug Resistance, Multiple; Febrile Neutropenia; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prevalence; Prospective Studies; Risk Factors; Sepsis; Singapore; Tazobactam; Treatment Outcome; Universities | 2012 |
Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Female; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2013 |
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones | 2002 |
Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: comparison of in vitro and animal models.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Carbapenems; Ceftazidime; Cephalosporins; Colony Count, Microbial; Computer Simulation; Endotoxins; Female; Lipopolysaccharides; Microscopy, Phase-Contrast; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley | 2003 |
Clinical experiences of bacteremia caused by metallo-beta-lactamase-producing gram-negative organisms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Child; Child, Preschool; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2004 |
IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Hospitals, Teaching; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Infections of cefotaxime-resistant and cefmetazole-susceptible Escherichia coli and Klebsiella pneumoniae in children.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheterization; Cefmetazole; Cefotaxime; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Heart Defects, Congenital; Humans; Immunologic Deficiency Syndromes; Infant; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Neoplasms; Premature Birth; Taiwan | 2005 |
Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Critical Care; Diabetes Complications; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome | 2005 |
Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2005 |
Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Brazil; Carbapenems; Cephalosporins; Cohort Studies; Costs and Cost Analysis; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome | 2006 |
Risk factors for isolation of strains susceptible only to polymyxin among patients with Pseudomonas aeruginosa bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2006 |
Emergence of carbapenem resistance in Acinetobacter baumannii recovered from blood cultures in Australia.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Microbial; Humans; Victoria | 2006 |
Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.
Topics: Adult; Aged; Bacteremia; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Middle Aged; Retrospective Studies; Risk Factors | 2006 |
Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Child; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Nepal; Paratyphoid Fever; Salmonella Infections; Salmonella paratyphi A; Salmonella typhimurium; Sentinel Surveillance | 2006 |
Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Rate; Taiwan; Treatment Outcome | 2006 |
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical | 2006 |
Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.
Topics: Adult; Aged; Bacteremia; Carbapenems; Case-Control Studies; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Neoplasms; Neutropenia; Pneumonia, Bacterial; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Texas | 2007 |
Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Treatment Outcome | 2007 |
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Prospective Studies; Risk Factors | 2007 |
Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; beta-Lactamases; Blotting, Western; Carbapenems; Carrier Proteins; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Female; Hospitals, University; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2007 |
Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Blood; Carbapenems; Cohort Studies; Colistin; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillins; Quinolones; Retrospective Studies; Risk Factors | 2007 |
Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2008 |
Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
Topics: Adult; Aged; Aminoglycosides; Bacteremia; Carbapenems; Case-Control Studies; Cross Infection; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Texas; Vancomycin Resistance | 2007 |
Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.
Topics: Bacteremia; beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae | 2008 |
Nosocomial bloodstream infection in a pediatric intensive care unit.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Incidence; India; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Medical Records; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome; Vancomycin | 2008 |
Increasing incidence of carbapenem-resistant Pseudomonas aeruginosa bacteraemia in a cancer centre over a seven-year period.
Topics: Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Incidence; Pseudomonas Infections; Retrospective Studies; Thienamycins | 1997 |
Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model.
Topics: Bacteremia; Carbapenems; Drug Administration Schedule; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 1997 |
The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen.
Topics: Bacteremia; Carbapenems; Cross Infection; Gram-Negative Bacterial Infections; Humans; Kuwait; Microbial Sensitivity Tests; Prospective Studies; Wound Infection; Xanthomonas | 1999 |
Meropenem pharmacokinetics in a patient with multiorgan failure from Meningococcemia undergoing continuous venovenous hemodiafiltration.
Topics: Adult; Bacteremia; Carbapenems; Chromatography, High Pressure Liquid; Hemodiafiltration; Humans; Male; Meningococcal Infections; Meropenem; Multiple Organ Failure; Thienamycins | 1999 |
Nosocomial bloodstream infections in a Turkish university hospital: study of Gram-negative bacilli and their sensitivity patterns.
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; In Vitro Techniques; Turkey | 2001 |